10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549

FORM 10-Q

(Mark One)

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the nine months period ended September 30, 2014

or

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________________ to _______________________

Commission File Number: 000-53769

LiqTech International, Inc.

(Exact name of registrant as specified in its charter)

Nevada	20-1431677
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
Industriparken 22C, DK2750 Ballerup, Denmark
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: +4544986000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer		Accelerated filer
Non-accelerated filer	(Do not check if a smaller reporting company)	Smaller reporting company	☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐. No ☒ .

The number of shares outstanding of the registrant’s common stock, par value $0.001 per share, at November 12, 2014, was 39,304,782 shares.  

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

Quarterly Report on Form 10-Q

For the Period Ended September 30, 2014

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements	4
Consolidated Balance Sheets as of September 30, 2014 (unaudited) and December 31, 2013	4
Consolidated Statements of Operations and Comprehensive Income for the Three and Nine Months Ended September 30, 2014 and September 30, 2013 (unaudited)	6
Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2014 and September 30, 2013 (unaudited)	8
Notes to Consolidated Financial Statements (unaudited)	9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operation	21
Item 3. Quantitative and Qualitative Disclosures About Market Risk	29
Item 4. Controls and Procedures	29
PART II. OTHER INFORMATION
Item 1A. Risk Factors	29
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 3. Defaults Upon Senior Securities	30
Item 4. Mine Safety Disclosures	30
Item 5. Other Information	30
Item 6. Exhibits	30
SIGNATURES	35

FORWARD-LOOKING STATEMENTS

Certain statements made in this Quarterly Report on Form 10-Q are “forward-looking statements” regarding the plans and objectives of management for future operations and market trends and expectations.  Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties.  Our plans and objectives are based, in part, on assumptions involving the continued expansion of our business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control.  Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this report will prove to be accurate.  In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved.  We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	As of September 30,		As of December 31,
	2014		2013
	UNAUDITED
Current Assets:
Cash	$	6,736,113	$	4,884,275
Accounts receivable, net		3,804,426		2,341,070
Other receivables		261,594		231,998
Cost in excess of billing		1,065,279		406,997
Inventories		5,397,011		4,258,606
Prepaid expenses		89,210		12,021
Current deferred tax asset		133,927		104,143
Total Current Assets		17,487,560		12,239,110
Property and Equipment, net accumulated depreciation		4,856,957		5,829,404
Other Assets:
Other investments		6,297		6,882
Long term deferred tax asset		3,022,692		1,863,349
Goodwill		7,980,327		-
Other intangible assets, net		18,630		24,687
Deposits		265,408		271,916
Total Other Assets		11,293,354		2,166,834
Total Assets	$	33,637,871	$	20,235,348

The accompanying notes are an integral part of these unaudited financial statements. 

4

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	As of September 30,			As of December 31,
	2014			2013
	UNAUDITED
Current Liabilities:
Lines of credit	$	2,406		$	-
Current portion of capital lease obligations		181,595			208,419
Accounts payable		2,077,934			1,586,962
Accrued expenses		1,254,048			1,440,522
Billing in excess of cost		45,348			96,104
Accrued income taxes payable		-			2,000
Deferred revenue / customer deposits		75,801			1,212,434
Total Current Liabilities		3,637,132			4,546,441
Long-term capital lease obligations, less current portion		436,588			554,360
Total Long-Term Liabilities		436,588			554,360
Total Liabilities		4,073,720			5,100,801
Stockholder’s Equity:
Common stock; par value $0.001, 100,000,000 shares authorized, 39,304,782 and 27,212,500 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively		39,305			27,213
Additional paid-in capital		35,568,888			18,700,574
Accumulated deficit		(3,486,851	)		(2,316,784	)
Deferred compensation		(526,568	)		(1,008,450	)
Other comprehensive income, net		(2,046,330	)		(292,565	)
Non-controlled interest in subsidiaries		15,707			24,559
Total Stockholders' Equity		29,564,151			15,134,547
Total Liabilities and Stockholder’s Equity	$	33,637,871		$	20,235,348

The accompanying notes are an integral part of these unaudited financial statements. 

5

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

(UNAUDITED) CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Net Sales	$	4,931,406		$	2,949,605		$	12,102,595		$	9,154,674
Cost of Goods Sold		3,464,284			2,675,132			9,229,131			8,025,657
Gross Profit		1,467,122			274,473			2,873,464			1,129,017
Operating Expenses:
Selling expenses		831,990			654,005			2,430,814			1,943,522
General and administrative expenses		738,761			568,944			2,174,942			1,773,073
Non-cash compensation expenses		(19,663	)		276,969			372,960			1,051,857
Research and development expenses		83,113			92,276			223,532			350,515
Total Operating Expense		1,634,201			1,592,194			5,202,248			5,118,967
Loss from Operations		(167,079	)		(1,317,721	)		(2,328,784	)		(3,989,950	)
Other Income (Expense)
Interest and other income		16,032			9,313			29,777			11,713
Interest (expense)		(18,794	)		(14,381	)		(40,914	)		(39,038	)
Gain (loss) on investments		9			-			(832	)		-
Gain (loss) on currency transactions		237,551			115,011			192,226			78,037
Loss on sale of fixed assets		-			-			-			(2,135	)
Total Other Income (Expense)		234,798			109,943			180,257			48,577
Income (Loss) Before Income Taxes		67,719			(1,207,778	)		(2,148,527	)		(3,941,373	)
Income Tax Expense (Benefit)		(276,870	)		(303,784	)		(972,430	)		(1,045,307	)
Net Income (Loss)		344,589			(903,994	)		(1,176,097	)		(2,896,066	)
Less Net Income (Loss) Attributable To Non-Controlled Interests in Subsidiaries		(2,915	)		(38	)		(6,029	)		(14,197	)
Net Income (Loss) Attributable To LiqTech	$	347,504		$	(903,956	)	$	(1,170,068	)	$	(2,881,869	)
Basic Earnings (Loss) Per Share	$	0.01		$	(0.04	)	$	(0.04	)	$	(0.12	)
Weighted Average Common Shares Outstanding		35,613,164			24,511,500			30,043,493			24,329,082
Diluted Earnings (Loss) Per Share	$	0.01		$	(0.04	)	$	(0.04	)	$	(0.012	)
Weighted Average Common Shares Outstanding Assuming Dilution		36,034,570			24,511,500			30,043,493			24,329,082

The accompanying notes are an integral part of these financial statements.

6

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

(UNAUDITED) CONSOLIDATED STATEMENTS OF OTHER

COMPREHENSIVE INCOME

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
	2014			2013			2014			2013
Net Income (Loss)		344,589			(903,994	)		(1,176,097	)		(2,896,066	)
Currency Translation, Net of Taxes		(1,852,400	)		93,635			(1,874,600	)		70,836
Other Comprehensive Income (Loss)	$	(1,507,811	)	$	(810,359	)	$	(3,050,697	)	$	(2,825,230	)
Comprehensive Income (Loss) Attributable To Non-controlling Interest in Subsidiaries		(1,745	)		920			(1,928	)		704
Comprehensive Income (Loss) Attributable To LiqTech International Inc.	$	(1,506,066	)	$	(811,279	)	$	(3,048,769	)	$	(2,825,934	)

The accompanying notes are an integral part of these financial statements.

7

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

(UNAUDITED) CONSOLIDATED STATEMENTS OF CASH FLOWS

Increase (Decrease) in Cash and Cash Equivalents

	For the Nine Months Period
	Ended September 30,
	2014			2013
Cash Flows from Operating Activities:
Net Loss	$	(1,176,097	)	$	(2,896,066	)
Adjustments to reconcile net loss to net cash provided by operations:
Depreciation and amortization		1,264,536			1,220,264
Non-cash compensation		372,960			1,051,857
Bad debt expense		131,111			45,425
Obsolete inventory expense		-			143,135
Change in deferred tax asset / liability		(893,309	)		(1,058,739	)
(Gain) Loss on sale of equipment		-			2,135
Changes in assets and liabilities:
(Increase) decrease in accounts receivable		9,570			1,177,222
(Increase) decrease in inventory		434,124			(919,145	)
(Increase) decrease in prepaid expenses/deposits		(54,803	)		64,128
Increase (decrease) in accounts payable		(1,146,846	)		(845,102	)
Increase (decrease) in accrued expenses		(2,211,334	)		76,888
Increase (decrease) long term contracts		(438,682	)		(294,416	)
Total Adjustments		(2,532,673	)		663,652
Net Cash Provided (Used) by Operating Activities		(3,708,770	)		(2,232,414	)
Cash Flows from Investing Activities:
Purchase of property and equipment		(190,440	)		(392,555	)
Acquisition of Provital Solutions AS		(1,874,684	)		-
Purchase of long-term investments		-			(23,090	)
Net Cash Used by Investing Activities		(2,065,124	)		(415,645	)
Cash Flows from Financing Activities:
Payments on notes payable		(131,559	)		-
Net payment on lines of credit		(1,791,895	)		-
Net (payments) on capital lease obligation		(144,596	)		(132,144	)
Proceeds from issuance of common stock and warrants		12,071,250			450,000
Payment of stock offering costs		(1,149,096	)		-
Net Cash Provided by Financing Activities		8,854,104			317,856
Loss on Currency Translation		(1,228,372	)		19,517
Net Increase (Decrease) in Cash and Cash Equivalents		1,851,838			(2,310,686	)
Cash and Cash Equivalents at Beginning of Period		4,884,275			3,873,338
Cash and Cash Equivalents at End of Period	$	6,736,113		$	1,562,652
Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for:
Interest	$	40,914		$	39,038
Income Taxes	$	1,000		$	1,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Compensation upon vesting of stock options (pre-vested forfeitures) granted to employees and the board of directors	$	(6,439	)	$	328,613
Compensation for vesting of restricted stock awards issued to the board of directors		319,999			284,444
Value of stock issued to acquire Provital Solutions AS		6,067,173			-
Value of stock granted for services		-			320,000
Value of warrants issued for services		59,400			118,800
Total	$	6,440,133		$	1,051,857

The accompanying notes are an integral part of these financial statements.

8

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business and Basis of Presentation

The consolidated financial statements include the accounts of LiqTech International, Inc. (“Parent”) and its subsidiaries. The terms "Company", “us", "we" and "our" as used in this report refer to Parent and its subsidiaries, which are set forth below. The Company engages in the development, design, production, marketing and sale of atuomated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America. Set forth below is a description of Parent and each of its subsidiaries:

LiqTech International, Inc., a Nevada corporation organized in July 2004, formerly known as Blue Moose Media, Inc.

LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in May 2011.

LiqTech International AS, a Danish corporation, incorporated on January 15, 2000 (“LiqTech Int. DK”), a 100% owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.

LiqTech NA, Inc. (“LiqTech NA”), incorporated in Delaware on July 1, 2005, a 100% owned subsidiary of LiqTech USA as of December 31, 2013, prior to December 31, 2013 LiqTech NA, Inc. was owned 90% by LiqTech International AS and 10% by LiqTech USA, LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.

LiqTech Asia (“LiqTech Asia”) a 60% owned subsidiary of LiqTech Int. DK, incorporated in South Korea on July 20, 2006, is currently a dormant subsidiary.

LiqTech Germany (“LiqTech Germany”) a 100% owned subsidiary of LiqTech Int. DK, incorporated in Germany on December 9, 2011, engages in marketing and sale of liquid filters in Germany.

LiqTech PTE Ltd, (“LiqTech Sing”) a 95% owned subsidiary of LiqTech Int. DK, incorporated in Singapore on January 19, 2012, engages in marketing and sale of liquid filters in Singapore and other countries in the area.

Provital Solutions AS, a Danish Corporation ("Provital") was incorporated on September 1, 2009 and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of Provital from the date of acquisition on July 31st, 2014.

The accompanying financial statements are unaudited. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2014 and 2013 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2013 audited financial statements. The results of operations for the periods ended September 30, 2014 and 2013 are not necessarily indicative of the operating results for the full year.

Consolidation--The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.

Functional Currency / Foreign currency translation -- The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The Functional Currency of LiqTech Int. DK and Provital Solutions AS is the Danish Krone (“DKK”), the functional currency of LiqTech Germany is the Euro and the functional currency of LiqTech Singapore is the Singapore Dollar, the functional Currency of LiqTech Asia is South Korean Won. The Company’s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the periods ended September 30, 2014 and 2013. Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.

9

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Cash and Cash Equivalents-- The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company had no balances held in financial institution in the United States in excess of federally insured amounts at September 30, 2014 and December 31, 2013.

Accounts Receivable-- Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence.

The roll forward of the allowance for doubtful accounts for the nine months ended September 30, 2014 and the year ended December 31, 2013 is as follows:

	2014			2013
Allowance for doubtful accounts at the beginning of the period	$	608,356		$	1,243,500
Bad debt expense		131,111			72,548
Acquired in purchase of Provital Solutions AS		253,584			-
Amount of receivables written off		-			(770,738	)
Effect of currency translation		(80,846	)		63,046
Allowance for doubtful accounts at the end of the period	$	912,205		$	608,356

Inventory-- Inventory is carried at the lower of cost or market, as determined on the first-in, first-out method.

Property and Equipment-- Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets which range from three to ten years (See Note 3).

Long-Term Investments-- Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information may be more limited, may not be as timely as and may be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.

Intangible Assets-- Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC”) Topic 350, “Goodwill and Other Intangible Assets” and amortized the patents on a straight line basis over the estimated useful life of two to ten years.  

Goodwill - Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.

Revenue Recognition and Sales Incentives-- The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (SAB 101), FASB ASC 605 Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collection of the resulting receivable is reasonable assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.

The Company has received various long-term contracts for the manufacturing and installation of water filtration and treatment systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long term or grant multiplied by the contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.

10

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Project costs of the long term contracts and grants include all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.

In Denmark, Value Added Tax (“VAT”) of 25% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.

Advertising Cost-- Cost incurred in connection with advertising of the Company’s products is expensed as incurred. Such costs amounted to $17,120 and $30,556, for the nine months ended September 30, 2014 and 2013, respectively.

Research and Development Cost-- The Company expenses research and development costs for the development of new products and systems as incurred. Included in operating expense for the nine months ended September 30, 2014 and 2013 were $223,532, and $350,515, respectively, of research and development costs.

Income Taxes-- The Company accounts for income taxes in accordance with FASB ASC Topic 740 Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.

Income (Loss) Per Share-- The Company calculates earnings (loss) per share in accordance with FASB ASC 260 Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options that have been granted but have not been exercised.

Stock Options-- The Company has granted stock options to certain employees. See Note 13. During the years presented in the accompanying consolidated financial statements, the Company has granted options. The Company accounts for options in accordance with the provisions of FASB ASC Topic 718, Compensation – Stock Compensation. Non-cash compensation costs of $372,960 and $1,051,857 have been recognized for the estimated vesting of options granted to employees with an associated recognized tax benefit of $0 for the nine months ended September 30, 2014 and 2013, respectively.

Fair Value of Financial Instruments-- The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic 820. The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

● Level 1. Observable inputs such as quoted prices in active markets for identical assets or liabilities;

● Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

● Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.

Accounting Estimates-- The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.

11

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Recent Accounting Pronouncements-- In May 2014, the Financial Accounting Standards Board issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard is effective beginning in the first quarter of 2017; early adoption is prohibited. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method nor have we determined the impact of the new standard on our consolidated condensed financial statements. 

NOTE 2 – INVENTORY

Inventory consisted of the following at September 30, 2014 and December 31, 2013:

	2014			2013
Furnace parts and supplies	$	1,146,003		$	1,025,225
Raw materials		1,683,858			631,524
Work in process		1,585,494			1,799,888
Finished goods and filtration systems		1,090,110			1,062,865
Reserve for obsolescence		(108,454	)		(260,896	)
Net Inventory	$	5,397,011		$	4,258,606

NOTE 3 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at September 30, 2014 and December 31, 2013:

	Useful Life		2014			2013
Production equipment		3 - 10	$	11,045,097		$	11,542,740
Lab equipment		3 - 10		166,019			181,432
Computer equipment		3 - 5		300,837			276,013
Vehicles		3		99,151			38,221
Furniture and fixture		5		136,101			68,169
Leasehold improvements		10		1,049,766			1,059,605
				12,796,971			13,166,180
Less Accumulated Depreciation				(7,940,014	)		(7,336,776	)
Net Property and Equipment			$	4,856,957		$	5,829,404

Depreciation expense amounted to $1,258,479 and $1,216,745, for the nine months ended September 30, 2014 and 2013, respectively. 

NOTE 4 – INVESTMENTS

The following tables summarize Level 1, 2 and 3 financial assets and financial (liabilities) by their classification in the Statement of Financial Position:

As of September 30, 2014	Level 1		Level 2		Level 3
Investments		-		-		6,297
Total		-		-		6,297

As of December 31, 2013	Level 1		Level 2		Level 3
Investments		-		-		6,882
Total		-		-		6,882

At September 30, 2014 and December 31, 2013, our total investments of $6,297 and $6,882 consisted of an investment in LEA Technology in France to strengthen our sales channels in the French market, respectively.

12

NOTE 5 - DEFINITE-LIFE INTANGIBLE ASSETS / GOODWILL AND INDEFINITE-LIFE INTANGIBLE ASSETS

Definite-Life Intangible assets - At September 30, 2014 and December 31, 2013, definite-life intangible assets, net of accumulated amortization, consisted of patents on the Company’s products of $18,630 and $24,687, respectively. The patents are recorded at cost and amortized over two to ten years. Amortization expense for the nine months ended September 30, 2014 and 2013 was $6,057 and $3,519, respectively.

Expected future amortization expense for the years ended are as follows: 

Year ending December 31,	Amortization Expenses
2014	$	1,325
2015		5,299
2016		5,299
2017		3,218
2018		2,707
Thereafter		782
Total Amortization Expenses	$	18,630

Goodwill - The following is a summary of goodwill:

	For the periods ended
	September 30, 2014			December 31, 2013
Goodwill at beginning of period	$	-		$	-
Goodwill resulting from the Provital acquisition		8,547,540			-
Effect of currency translation		(567,213	)		-
Goodwill at end of period	$	7,980,327		$	-

Goodwill consists of:

	For the periods ended
	September 30, 2014		December 31, 2013
Provital Solutions AS	$	7,980,327	$	-
Total Goodwill	$	7,980,327	$	-

NOTE 6 — LINES OF CREDIT

Provital Solutions AS has a DKK 2,000,000 (approximately $340,000 at September 30, 2014) standby line of credit with a bank, subject to certain borrowing base limitations. Outstanding borrowings are due on demand. Interest is calculated based on a variable interest rate and is payable quarterly. As of September 30, 2014, the interest on this line of credit was at 3.50%. This line of credit is guaranteed by Vækstfonden (the Danish state's investments fund) and is also secured by certain of Provital Solutions AS’ assets like receivables, inventory, equipment etc. There was $2,406 outstanding as of September 30, 2014. At September 30, 2014, there was approximately $335,000 available under this credit line. In general, lines of credit in Denmark are due on demand. We do not believe that any of our lines of credit will be called, but if they were called, we believe that we could refinance with other lenders in Denmark with similar terms.

In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a credit line of DKK 5,000,000 (approximately $845,000 at September 30, 2014) with a bank, subject to certain base limitations. As of September 30, 2014, we had DKK 1,379,646 (approximately $230,000)  in working guarantee against the line.

13

NOTE 7 – LEASES

Operating Leases-- The Company leases office and production facilities under operating lease agreements expiring in August 2018, March 2017, February 2017, June 2017, December 2016 and June 2016. In some of these lease agreements, the Company has the right to extend.

The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of one year as of September 30, 2014 are as follows:

Year ending December	Operating Lease Payments
2014	$	169,334
2015		695,240
2016		693,791
2017		482,503
2018		287,962
Thereafter		-
Total Minimum Lease Payments	$	2,328,830

Lease expense charged to operations was $539,443 and $578,313 for the nine months ended September 30, 2014 and 2013, respectively.

Capital Leases -- The Company leases equipment on various variable rate capital leases currently calling for monthly payments of approximately $11,112, $4,306, $2,788, $2,152, $704 and $634 expiring through February 2018. Included in property and equipment, at September 30, 2014 and December 31, 2013, the Company had recorded equipment on capital lease at $1,531,714 and $1,600,254, respectively, with related accumulated depreciation of $975,838 and $907,728, respectively. 

During the nine months ended September 30, 2014 and 2013, depreciation expense for equipment on capital lease amounted to $153,378, and $160,993, respectively, and has been included in depreciation expense. During the nine months ended September 30, 2014 and 2013, interest expense on a capital lease obligation amounted to $30,227 and $38,442, respectively.

Future minimum capital lease payments are as follows for the periods ended December 31: 

	Capital Lease Payments
2014	$	70,077
2015		223,548
2016		216,916
2017		145,029
2018		28,282
Thereafter		-
Total minimum lease payments		683,852
Less amount representing interest		(65,669	)
Present value of minimum lease payments		618,183
Less current portion		(181,595	)
Long-term lease payments	$	436,588

NOTE 8 – AGREEMENTS AND COMMITMENTS

401(K) Profit Sharing Plan-- LiqTech NA has a 401(k) profit sharing plan and trust covering certain eligible employees. The amount LiqTech NA contributes is discretionary. For the nine months ended September 30, 2014 and 2013, matching contributions were expensed and totaled $12,110 and $11,902, respectively.

In connection with some orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a credit line of DKK 5,000,000 (approximately $845,000 at September 30, 2014) with a bank, subject to certain base limitations. As of September 30, 2014, we had DKK 1,379,646 (approximately $230,000) in working guarantee against the line.

14

 NOTE 9 – INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC Topic 740, Accounting for Income Taxes; which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carry forwards. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company’s future earnings, and other future events, the effects of which cannot be determined.

The temporary differences, tax credits and carry forwards gave rise to the following deferred tax asset (liabilities) at September 30, 2014 and December 31, 2013:  

	2014			2013
Vacation accrual	$	4,161		$	4,161
Allowance for doubtful Accounts		31,566			13,955
Long term contracts		13,036			-
Reserve for obsolete inventory		85,164			86,027
Net current tax assets	$	133,927		$	104,143
Business tax credit carryover		20,184			20,184
Deferred compensation		202,309			202,309
Net operating loss carryover		3,525,333			2,367,568
Excess of book over tax depreciation		(725,134	)		(726,712	)
Long term deferred tax asset	$	3,022,692		$	1,863,349

In accordance with prevailing accounting guidance, the Company is required to recognize and disclose any income tax uncertainties. The guidance provides a two-step approach to recognizing and measuring tax benefits and liabilities when realization of the tax position is uncertain. The first step is to determine whether the tax position meets the more-likely-than-not condition for recognition and the second step is to determine the amount to be recognized based on the cumulative probability that exceeds 50%.

The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company’s future earnings, and other future events, the effects of which can difficult to determine and can only be estimated. Management estimates that it is more likely than not that the Company will generate adequate net profits to use the deferred tax assets; management has estimated that all of the deferred tax will be realized and consequently, a valuation allowance was not recorded.

A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company’s effective rate is as follows for the nine months ended September 30, 2014 and 2013: 

	2014			2013
Computed tax at expected statutory rate	$	(1,107,897	)	$	(1,335,240	)
State and local income taxes, net of federal benefits		(24,703	)		(15,743	)
Non-deductible expenses		52,174			205,498
Non-US income taxed at different rates		107,996			100,735
Other items		-			(557	)
Income tax (benefit)	$	(972,430	)	$	(1,045,307	)

15

The components of income tax expense (benefit) from continuing operations for the nine months ended September 30, 2014 and 2013 consisted of the following:

	2014			2013
Current income tax expense:
Danish	$	-		$	-
Korean		1,020			-
Federal		-			-
State		-			-
Current tax expense	$	1,020		$	-
Net operating loss carryover		(973,450	)		(1,032,389	)
Allowance for doubtful accounts		-			-
Reserve for obsolete inventory		-			(12,918	)
Deferred tax expense	$	(973,450	)	$	(1,045,307	)
Income tax benefit	$	(972,430	)	$	(1,045,307	)

Deferred income tax expense / (benefit) results primarily from the reversal of temporary timing differences between tax and financial statement income. 

The Company files Danish and U.S. federal and Minnesota state income tax returns. LiqTech International AS is generally no longer subject to tax examinations for years prior to 2011 for their Danish tax returns. LiqTech NA is generally no longer subject to tax examinations for years prior to 2009 for U.S. federal and U.S. states tax returns.

NOTE 10 – EARNINGS PER SHARE

The following data shows the amounts used in computing earnings per share and the effect on income and the weighted average number of shares of potential dilutive common stock for the nine months ended September 30, 2014 and 2013:

	For the Three Months Ended September 30					For the Nine Months Ended September 30
	2014		2013			2014			2013
Income (Loss) attributable to LiqTech International Inc.	$	347,504	$	(903,956	)	$	(1,170,068	)	$	(2,881,869	)
Weighted average number of common shares used in basic earnings per share		35,613,164		24,511,500			30,043,493			24,329,082
Effect of dilutive securities, stock options and warrants		-		-			-			-
Weighted average number of common shares and potentially dilutive securities	$	36,034,570	$	24,511,500		$	30,043,493		$	24,329,082

For the nine months ended September 30, 2014, Parent had 2,416,630 options outstanding to purchase common stock of the Parent at $1.50 to $3.60 per share and Parent had 7,425,575 warrants outstanding to purchase common stock of the Parent at $1.50 to $4.06 per share, which were not included in the loss per share computation because their effect would be anti-dilutive.

For the nine months ended September 30, 2013, Parent had 2,564,130 options outstanding to purchase common stock of the Parent at $1.50 to $3.60 per share and Parent had 7,025,575 warrants outstanding to purchase common stock of the Parent at $1.50 to $4.06 per share, which were not included in the loss per share computation because their effect would be anti-dilutive.

NOTE 11 - STOCKHOLDERS' EQUITY

Common Stock  --  Parent has 100,000,000 authorized shares of common stock, $0.001 par value. As of September 30, 2014 and December 31, 2013, respectively, there were 39,304,782 and 27,212,500 common shares issued and outstanding.    

Voting -- Holders of Parent common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors, and do not have any right to cumulate votes in the election of directors. 

Dividends -- Subject to the rights and preferences of the holders of any series of preferred stock which may at the time be outstanding, holders of Parent common stock are entitled to receive ratably such dividends as our Board of Directors from time to time may declare out of funds legally available. 

16

Liquidation Rights -- In the event of any liquidation, dissolution or winding-up of affairs of Parent, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock, the holders of Parent common stock will be entitled to share ratably in the distribution of any of our remaining assets.  

Other Matters -- Holders of Parent common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions with respect to the common stock. All of the issued and outstanding shares of common stock on the date of this report are validly issued, fully paid and non-assessable.

Preferred Stock -- Our Board of Directors has the authority to issue Parent preferred stock in one or more classes or series and to fix the designations, powers, preferences and rights, the qualifications, limitations or restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without further vote or action by the stockholders. The issuance of Parent preferred stock may have the effect of delaying, deferring or preventing a change in control of us without further action by the stockholders and may adversely affect the voting and other rights of the holders of common stock.

Common Stock Issuance

On July 28, 2014, Parent completed a registered public offering of its common stock. As part of the closing, Parent issued 8,000,000 shares of common stock at a per share price of $1.50 and generated net proceeds of approximately $10.8 million, net of offering costs of $1,149,096. 

On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Provital Shares”) of Provital Solutions A/S, a Danish company (“Provital”) and as part of the consideration for the Provital Shares, the Company issued 4,044,782 common shares. 

During the third quarter 2014, the Company issued 47,500 shares of common stock in connection with the exercise of 47,500 stock options with an exercise price of $1.50 each.

During the year 2013, the Company issued 100,000 shares of common stock valued at $320,000 for services rendered.

The Company issued an additional 300,000 shares of restricted stock valued at $960,000 for services provided and to be provided by the board of directors. The Company will recognized the non-cash compensation of the award over the requisite service period, of which 133,333 shares vested on December 31, 2013, 133,333 shares will vest on December 31, 2014 and 33,334 shares will vest on December 31, 2015. As of September 30, 2014, the Company has recorded deferred compensation of $320,001 and non-cash compensation expense of $320,000 relating to the awards for the nine months ended September 30, 2014.

On October 9, 2013 we announced that the warrant and option exercise raised $4,051,000 with holders exercising 2,701,000 warrants and stock options which included the exercise of 100,000 warrants by Aldo Petersen, Chairman of LiqTech, 25,000 stock options by Lasse Andreassen, founder and former board member of LiqTech and 50,000 stock options by Soren Degn, CFO of LiqTech. The board noted that the additional capital was an orderly solution to improving the Company's capital structure as well as enhancing the ability of LiqTech to list on an exchange. In addition, the new capital gave the Company additional flexibility to generate new orders and to sustain future growth.

Common Stock Purchase Warrants

A summary of the status of the Warrants outstanding at September 30, 2014 is presented below:

		Warrants Outstanding						Warrants Exercisable
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50		3,874,000		2.25	$	1.50		3,874,000	$	1.50
$	1.65		400,000		4.83	$	1.65		400,000	$	1.65
$	2.35		400,000		0.50	$	2.35		400,000	$	2.35
$	2.70		2,626,000		2.25	$	2.70		2,626,000	$	2.70
$	4.0625		125,575		2.43	$	4.0625		125,575	$	4.06
Total			7,425,575		2.30	$	2.02		7,425,575	$	2.02

17

At September 30, 2014, the Company had no non-vested warrants. We have recorded non-cash compensation expense of $59,400 for the period ended September 30, 2014 related to the warrants issued.

The exercise price of the warrants and the number of shares underlying the warrants are subject to adjustment for stock dividends, subdivisions of the outstanding shares of common stock and combinations of the outstanding shares of common stock. For so long as the warrants remain outstanding, we are required to keep reserved from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of the shares underlying the warrants.

On July 28, 2014, the Company issued to the Underwriter in our public offering, for a price of $50, a warrant to purchase 400,000 shares at an exercise price of $1.65 per share. The warrants are immediately exercisable and will remain exercisable for five years.

On October 9, 2013, the Company issued 2,626,000 new warrants equal to the number of warrants exercised by the warrant holder having the same terms and conditions as the warrants exercised by the warrant holder, respectively, except each warrant issued has a strike price of $2.70 per share, the closing bid price of Parent’s common stock as quoted on the OTCBB on September 23, 2013.  The net proceeds from the offering were allocated to the stock and warrants based on their relative fair values. The Company recorded the relative fair value of the warrants of $1,124,928 as stock offering costs.

Stock Options

In August 2011, Parent’s Board of Directors adopted a Stock Option Plan (the “Plan”). Under the terms and conditions of the Plan, the board is empowered to grant stock options to employees, officers, and directors of the Companies. At September 30, 2014, 2,416,630 options were granted and outstanding under the Plan. 

The Company recognizes compensation costs for stock option awards to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average assumptions used to estimate the fair values of the stock options granted using the Black-Scholes option-pricing model are as follows:

	LiqTech International, Inc.
Expected term (in years)		3-4
Volatility		40.74
Risk free interest rate		0.67	%
Dividend yield		0	%

The Company recognized stock based compensation expense (forfeitures) related to the options of $(6,439) and $613,057 for the nine months ended September 30, 2014 and 2013, respectively. At September 30, 2014 the Company had approximately $313,233 of unrecognized compensation cost related to non-vested options expected to be recognized through January 27, 2017.

A summary of the status of the options outstanding under the Company’s stock option plans at September 30, 2014 is presented below: 

		Options Outstanding						Options Exercisable
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50		330,000		0.40	$	1.50		330,000	$	1.50
$	1.90		500,000		2.33	$	1.90		166,667	$	1.90
$	2.70		75,000		0.40	$	2.70		75,000	$	2.70
$	3.00 - 3.60		1,511,630		0.41	$	3.06		1,511,630	$	3.06
Total			2,416,630		0.80	$	2.59		2,083,297	$	2.70

18

A summary of the status of the options at September 30, 2014, and changes during the period is presented below:

	September 30, 2014
	Shares			Weighted Average Exercise Price		Average Remaining Life		Weighted Average Intrinsic Value
Outstanding at beginning of period		2,564,130		$	2.65		1.64	$	283,125
Granted		500,000			1.90		2.33		-
Exercised		(47,500	)		1.50		-		-
Forfeited		(600,000	)		2.35		-		-
Expired		-			-		-		-
Outstanding at end of period		2,416,630		$	2.59		0.80	$	13,200
Vested and expected to vest		2,416,630		$	2.59		0.80	$	13,200
Exercisable end of period		2,083,297		$	2.70		0.56	$	13,200

At September 30, 2014, the Company had 333,333 non-vested options with a weighted average exercise price of $1.90 and with a weighted average grant date fair value of $0.805, resulting in unrecognized compensation expense of $313,233, which is expected to be expensed over a weighted-average period of 2.33 years.

The total intrinsic value of options at September 30, 2014 was $13,200. Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at September 30, 2014 (for outstanding options), less the applicable exercise price. 

NOTE 12 - SIGNIFICANT CUSTOMERS / CONCENTRATION

The Company had no customers that accounted for more than 10% of total sales at September 30, 2014 and 2013.

The Company sells products throughout the world; sales by geographical region are as follows for the three and nine months ended September 30, 2014 and 2013: 

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2014		2013		2014		2013
United States and Canada	$	1,066,463	$	736,958	$	2,841,932	$	2,264,368
Australia		179,981		55,093		264,296		223,483
South America		-		4,679		16,845		30,058
Asia		696,102		493,542		1,191,035		1,645,025
Europe		2,988,860		1,659,333		7,788,487		4,991,740
	$	4,931,406	$	2,949,605	$	12,102,595	$	9,154,674

The Company’s sales by product line are as follows for the three and nine months ended September 30, 2014 and 2013:

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2014		2013		2014		2013
Ceramic diesel particulate	$	1,519,204	$	1,386,565	$	5,137,720	$	4,858,841
Liquid filters and systems		3,256,689		1,440,849		6,639,362		3,679,719
Kiln furniture		155,513		122,191		325,513		616,114
	$	4,931,406	$	2,949,605	$	12,102,595	$	9,154,674

19

NOTE 13 – ACQUISITION

Acquisition -On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Provital Shares”) of Provital Solutions A/S, a Danish company (“Provital”) from Masu A/S, a Danish company (“MASU”). In consideration for the Provital Shares, MASU received cash consideration in the sum of DKK12,600,000, that is, approximately USD$2,300,000, and 4,044,782 shares of the Company’s common stock (the “Payment Shares”). One-third (1/3) of the Payment Shares shall be subject to a lock-up period of six (6) months. The remaining two-thirds (2/3) of the Payment Shares shall be held in escrow and one-third of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2014, achieving (i) gross revenues of not less than DKK65,000,000, that is, approximately USD$10,988,639 and EBITDA of DKK6,500,000, that is, approximately USD$1,098,864 or (ii) EBITDA of not less than DKK10,000,000, that is, approximately USD$1,690,560 and gross revenues of not less than DKK50,000,000, that is, approximately USD$8,452,800. Another one-third (1/3) of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2015, achieving (i) gross revenues of not less than DKK120,000,000, that is, approximately USD$20,286,719 and EBITDA of DKK12,000,000, that is, approximately USD$2,028,672 or (ii) EBITDA of not less than DKK16,000,000, that is, approximately USD$2,704,896 and gross revenues of not less than DKK80,000,000, that is, approximately USD$13,524,479.   

The purchase agreement includes “catch up” provisions that provide that the Payment Shares placed in escrow will be released from escrow if Provital (1) for the years ending December 31, 2014 and December 31, 2015, achieves accumulated gross revenues (i) exceeding DKK185,000,000, that is, approximately USD$31,275,358 and EBITDA of DKK18,500,000, that is, approximately USD$3,127,536 or (ii) EBITDA of not less than DKK26,000,000, that is, approximately USD$4,395,456 and gross revenues of not less than DKK130,000,000, that is, approximately USD$21,977,279 or (2) for the year ending December 31, 2016, achieves gross revenues exceeding DKK105,000,000, that is, approximately USD$17,750,879 and EBITDA of not less than DKK21,000,000, that is, approximately USD$3,550,176.

Current fair value of the consideration transferred to acquire Provital Solutions AS:

Cash	$	2,300,000
4,044,782 common shares at $1.50 a share		6,067,173
Current consideration transferred for the acquisition	$	8,367,173

Total consideration transferred was allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values at the acquisition date as set forth below. The Company believes that the acquisition of Provital Solutions AS facilitates the Company’s entry into the water filtration systems industry, diversifies its product revenue and enhances its strength in providing whole system offerings. These factors contributed to consideration transferred in excess of the fair value of Provital Solutions’ net tangible and intangible assets acquired, resulting in the Company recording goodwill in connection with the transaction. Management estimated the fair values of tangible and intangible asset and liabilities in accordance with the applicable accounting guidance for business combinations.

The Company’s allocation of consideration transferred for Provital Solutions AS is as follows:

	Estimated Fair Value
Cash	$	425,316
Accounts receivable, net		1,632,354
Other receivables		1,279
Cost in excess of billings		592,747
Inventory		1,572,529
Prepaid expenses		3,794
Current deferred tax asset		18,692
Property and equipment, net of accumulated depreciation		56,005
Deposits		12,084
Deferred tax asset long term		277,126
Goodwill		8,547,540
Total assets acquired	$	13,139,466
Lines of credit payable		(1,794,301	)
Accounts payable		(1,637,815	)
Accrued expense		(886,227	)
Billings in excess of cost		(322,391	)
Notes payable		(131,559	)
Total net assets acquired	$	8,367,173

Goodwill

The $8,547,540 of goodwill represents the excess of consideration transferred over the fair value of assets acquired and liabilities assumed and is attributable to the benefits expected from combining the Company’s operations with Provital Solutions AS. This goodwill is not deductible for income tax purposes.

NOTE 14 – SUBSEQUENT EVENTS

The Company’s management reviewed material events through November 12, 2014.

20

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report. In addition, the following discussion should be read in conjunction with our annual report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 27, 2014, and the financial statements and notes thereto. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

Overview

We are a clean technology company that provides state-of-the-art technologies for gas and liquid purification by manufacturing ceramic silicon carbide filters. For more than a decade, we have developed and manufactured products of re-crystallized silicon carbide. We specialize in two business areas: ceramic membranes for liquid filtration and diesel particulate filters for the control of soot exhaust particles from diesel engines. We are phasing out the fabrication of kiln furniture for the refractory industry. Using nanotechnology, we develop proprietary products using patented silicon carbide technology. Our products are based on unique silicon carbide membranes which facilitate new applications and improve existing technologies. We market our products from our offices in the United States and Denmark, and through local representatives in Singapore, Germany, France and Brazil. The products are shipped directly to customers from our production facilities in the United States and Denmark.

The terms “LiqTech”, “we”, “our”, “us”, the “Company” or any derivative thereof, as used herein refer to LiqTech International, Inc., a Nevada corporation, together with its direct and indirect wholly-owned subsidiaries, including LiqTech USA, Inc., a Delaware corporation (“LiqTech USA”), which owns all of the outstanding equity interest in LiqTech International A/S, a Danish limited company, organized under the Danish Act on Limited Companies of the Kingdom of Denmark (“LiqTech Int. DK”) and LiqTech NA, Inc., a Delaware corporation (“LiqTech Delaware”). Collectively, LiqTech USA, LiqTech Int. DK and LiqTech Delaware are referred to herein as our “Subsidiaries”. On August 23, 2012, LiqTech A/S, a Danish limited company (“LiqTech AS”) and former subsidiary of the Company was merged with and into LiqTech Int. DK.

Acquisition -On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Provital Shares”) of Provital Solutions A/S, a Danish company (“Provital”) from Masu A/S, a Danish company (“MASU”). In consideration for the Provital Shares, MASU received cash consideration in the sum of DKK12,600,000, that is, approximately USD$2,300,000, and 4,044,782 shares of the Company’s common stock (the “Payment Shares”). One-third (1/3) of the Payment Shares shall be subject to a lock-up period of six (6) months. The remaining two-thirds (2/3) of the Payment Shares shall be held in escrow and one-third of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2014, achieving (i) gross revenues of not less than DKK65,000,000, that is, approximately USD$10,988,639 and EBITDA of DKK6,500,000, that is, approximately USD$1,098,864 or (ii) EBITDA of not less than DKK10,000,000, that is, approximately USD$1,690,560 and gross revenues of not less than DKK50,000,000, that is, approximately USD$8,452,800. Another one-third (1/3) of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2015, achieving (i) gross revenues of not less than DKK120,000,000, that is, approximately USD$20,286,719 and EBITDA of DKK12,000,000, that is, approximately USD$2,028,672 or (ii) EBITDA of not less than DKK16,000,000, that is, approximately USD$2,704,896 and gross revenues of not less than DKK80,000,000, that is, approximately USD$13,524,479.   

The purchase agreement includes “catch up” provisions that provide that the Payment Shares placed in escrow will be released from escrow if Provital (1) for the years ending December 31, 2014 and December 31, 2015, achieves accumulated gross revenues (i) exceeding DKK185,000,000, that is, approximately USD$31,275,358 and EBITDA of DKK18,500,000, that is, approximately USD$3,127,536 or (ii) EBITDA of not less than DKK26,000,000, that is, approximately USD$4,395,456 and gross revenues of not less than DKK130,000,000, that is, approximately USD$21,977,279 or (2) for the year ending December 31, 2016, achieves gross revenues exceeding DKK105,000,000, that is, approximately USD$17,750,879 and EBITDA of not less than DKK21,000,000, that is, approximately USD$3,550,176.

We conduct operations in the Kingdom of Denmark and the United States. Our Danish operations are located in the Copenhagen area and Provital Solutions are located in Hobro in Jutland, Denmark, and our U.S. operations are conducted by LiqTech Delaware located in White Bear Lake, Minnesota. In October and December 2011, we opened sales offices in France and Germany and in January 2012, we opened a sales office in Singapore.

Our Strategy

Our strategy is to create shareholder value by leveraging our competitive strengths and focusing on the opportunities in the end-markets we serve. Key features of our strategy include:

● Enter New Geographic Markets and Expand Existing Markets. We will continue to manufacture and sell our products out of Denmark and the United States. In October 2011, the Company opened sales offices in France and Germany and in January 2012, we opened a sales office in Singapore. In 2014 we added 2 manufacturing facilities in Denmark through an acquisition and we intend to expand our United States manufacturing facility to include the manufacturing of complete systems. We are prepared to work closely with agents worldwide to offer local technical support. We will establish further sales offices and manufacturing facilities worldwide as we grow.

● Keep a Focused Application Strategy and Expand Gradually into New Application Areas. We currently sell our products for applications within the drinking water, waste water, industrial , oil & gas, the pool industry and emission control markets. We will be application specialists in our chosen application areas providing valuable know-how and added value to our customers. We will offer our customers a full array of products and services including everything  from stand-alone membranes to complete filtration systems. As we grow and develop new and better products we are fully prepared to expand into new applications as opportunities arise .

21 

● Continue to Strengthen Position in DPF Market. We have a strong position in the retrofit market for diesel particulate filter systems and we intend to maintain our strength in this area. Using our extensive experience serving the OEM market we will expand our presence in the OEM market with new products relating to diesel particulate filter systems.  Furthermore,  the global DPF is expected to show growth and we will actively pursue sales opportunities worldwide.

● Continue to Develop and Improve Technologies and Open New End Markets. We will maintain our focus on developing new green technology products as we continue to improve the filtration capabilities of our silicon carbide membranes. We will devote the necessary resources to develop new uses for our products and expand our product offerings with new products that complement our ceramic membranes. As an example, in November 2014 the Company announced it´s new LED-based Deep UV Water Treatment System. We intend to develop further LED-based UV products. We also plan on manufacturing a SiC membrane of 0.01 microns or less, which would position us to enter the ultrafiltration market.  We will expand into any new markets that we believe would be appropriate for our Company.

● Continue Our Focus on Developing an Inorganic Reverse Osmosis Membrane. There is no inorganic reverse osmosis membrane in the market today. In 2011, we received a $2 million grant from The Danish National Advanced Technology Foundation to develop a SiC-based membrane that can perform reverse osmosis. Over the next several years we will continue our research and development efforts to modify our membrane into one that can perform reverse osmosis.

Recent Developments

Recent Contract Wins

On October 14, 2014, we announced that the Company received a $200,000 SiC membrane system order from a Danish customer to be delivered this year. The membrane system will be installed at a Danish power plant to remove heavy metals from a heat recovery process. This sale represents LiqTech’s first commercial system sold to the energy industry as a joint supply effort by LiqTech and Provital, our recently acquired subsidiary.

On July 31, 2014, we announced that the Company received a $350,000 Silicon Carbide (SiC) membrane system order from a Danish customer to be delivered this year. The system will be installed at a Danish fish farm to filter seawater for its recirculated aquaculture system. The Danish fish farm will apply LiqTech’s SiC based membrane system to create a bio-secure facility and to prevent disease to spread from the sea water to the closed aquaculture system. LiqTech’s system together with Provital’s UV system will provide water quality ideal for the aquaculture plant.

On July 09, 2014, we announced that the company received a $200,000 SiC membrane order from a European customer to be delivered this year. The membranes will be installed at a German power plant to remove heavy metals from a flue gas cleaning process. LiqTech and the end-user have developed a solution around the SiC membranes that reduces the environmental impact from coal and biomass fired power plants.

Stock Offering

On July 22, 2014, the Company, entered into a purchase agreement with Craig-Hallum Capital Group LLC as Underwriter, pursuant to which the Company agreed to sell, and the Underwriter agreed to purchase for resale to the public an Offering, subject to the terms and conditions expressed therein, 6,956,522 shares of common stock of the Company, par value $0.001 per share at a price to the public of $1.50 per share. The Offering closed on July 28, 2014. The Company granted the Underwriter a 30-day option to purchase an additional 1,043,478 shares which was exercised by Craig-Hallum Capital Group LLC on July 25, 2014. The Company also issued to the Underwriter, for a price of $50, a warrant to purchase 400,000 shares at an exercise price of $1.65 per share. The warrants are immediately exercisable and will remain exercisable for five years.

Provital Acquisition

On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Provital Shares”) of Provital Solutions A/S, a Danish company (“Provital”) from Masu A/S, a Danish company (“MASU”). In consideration for the Provital Shares, MASU received cash consideration in the sum of DKK12,600,000, that is, approximately USD$2,300,000, and 4,044,782 shares of the Company’s common stock (the “Payment Shares”). One-third (1/3) of the Payment Shares shall be subject to a lock-up period of six (6) months. The remaining two-thirds (2/3) of the Payment Shares shall be held in escrow and one-third of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2014, achieving (i) gross revenues of not less than DKK65,000,000, that is, approximately USD$10,988,639 and EBITDA of DKK6,500,000, that is, approximately USD$1,098,864 or (ii) EBITDA of not less than DKK10,000,000, that is, approximately USD$1,690,560 and gross revenues of not less than DKK50,000,000, that is, approximately USD$8,452,800. Another one-third (1/3) of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2015, achieving (i) gross revenues of not less than DKK120,000,000, that is, approximately USD$20,286,719 and EBITDA of DKK12,000,000, that is, approximately USD$2,028,672 or (ii) EBITDA of not less than DKK16,000,000, that is, approximately USD$2,704,896 and gross revenues of not less than DKK80,000,000, that is, approximately USD$13,524,479.

22

The purchase agreement includes “catch up” provisions that provide that the Payment Shares placed in escrow will be released from escrow if Provital (1) for the years ending December 31, 2014 and December 31, 2015, achieves accumulated gross revenues (i) exceeding DKK185,000,000, that is, approximately USD$31,275,358 and EBITDA of DKK18,500,000, that is, approximately USD$3,127,536 or (ii) EBITDA of not less than DKK26,000,000, that is, approximately USD$4,395,456 and gross revenues of not less than DKK130,000,000, that is, approximately USD$21,977,279 or (2) for the year ending December 31, 2016, achieves gross revenues exceeding DKK105,000,000, that is, approximately USD$17,750,879 and EBITDA of not less than DKK21,000,000, that is, approximately USD$3,550,176.

Change in Officers and Appointment of Director

Effective July 29, 2014, the board of directors (the “Board”) of the Company, accepted the amicable resignation of Finn Helmer from his position as Chief Executive Officer of the Company. Effective July 30, 2014, the Board appointed Mr. Sune Mathiesen to serve as CEO and as a Board member of the Company. 

CEO Employment Agreement

On July 29, 2014, LiqTech Int. DK and Mr. Mathiesen entered into an Employment Agreement pursuant to which Mr. Mathiesen shall also serve as Director and Chief Executive Officer of the Company. In consideration for Mr. Mathiesen’s services to the Company, Mr. Mathiesen shall receive an annual base salary initially set at DKK 1,500,000 that is approximately $253,584. Mr. Mathiesen’s Employment Agreement also provides that he shall receive a yearly bonus of five percent (5%) of the average gross profit for LiqTech Int. DK and Provital Solutions A/S for any sales (revenue) greater than or equal to DKK130,000,000 that is approximately $21,977,279 per year. The calculation in connection with the bonus is described in the Employment Agreement. In addition, Mr. Mathiesen shall be entitled to five weeks’ vacation, a Company mobile phone, broadband connection in his residence, a Company laptop and reimbursement of Company-related travel expenses. The Company may terminate Mr. Mathiesen’s employment upon not less than 12 months’ notice and Mr. Mathiesen may terminate with 12 months’ notice to the end of the month. The contract is irrevocable from both parties until December 31, 2016.

Mr. Mathiesen has served as CEO and as a Director of MASU, a Danish company since February 2013. He has served as CEO and Director of the Board of Provital since March, 2012. Before that he served as Country Manager of Broen Lab Group since August 2010 and before that as Country Manager of GPA Flowsystem since February 2000. Mr. Mathiesen has a solid background in executive management, sales and corporate turn-arounds. Mr. Mathiesen has been working hands-on with technical products within the valves and fittings industry for the past 16 years. He has a degree in commercial science from Via College in Randers, Denmark.

23

Results of Operations

 The financial information below is derived from our unaudited condensed consolidated financial statements included elsewhere in this report.

 The following table sets forth our revenues, expenses and net income for the three and nine months ended September 30, 2014 and 2013:

	Three months ended September 30,
													Period to period change
	2014			As a % of Sales			2013			As a % of Sales			US$			Percent %
Net Sales		4,931,406			100	%		2,949,605			100	%		1,981,801			67.2
Cost of Goods Sold		3,464,284			70.2			2,675,132			90.7			789,152			29.5
Gross Profit		1,467,122			29.8			274,473			9.3			1,192,649			434.5
Operating Expenses
Selling and Marketing		831,990			16.9			654,005			22.2			177,985			27.2
General and Administrative		738,761			15.0			568,944			19.3			169,817			29.8
Non-cash compensation		(19,663	)		(0.4	)		276,969			9.4			(296,632	)		(107.1	)
Research and Development		83,113			1.7			92,276			3.1			(9,163	)		(9.9	)
Total Operating Expenses		1,634,201			33.1			1,592,194			54.0			42,007			2.6
Income (loss) from Operating		(167,079	)		(3.4	)		(1,317,721	)		(44.7	)		1,150,642			(87.3	)
Interest and Other Income		16,032			0.3			9,313			0.3			6,719			72.1
Interest (Expense)		(18,794	)		(0.4	)		(14,381	)		(0.5	)		(4,413	)		30.7
(Loss) on Investments		9			0.0			-			-			9		-
Gain (loss) on Currency Transactions		237,551			4.8			115,011			3.9			122,540			106.5
Gain (Loss) on Sale of Fixed Assets		-			-			-			-			-		-
Total Other Income (Expense)		234,798			4.8			109,943			3.7			124,855			113.6
Income Before Income Taxes		67,719			1.4			(1,207,778	)		(40.9	)		1,275,497			(105.6	)
Income Taxes Expense (Income)		(276,870	)		(5.6	)		(303,784	)		(10.3	)		26,914			(8.9	)
Net Income		344,589			7.0			(903,994	)		(30.6	)		1,248,583			(138.1	)
Less net income attributable to the non-controlled interest in subsidiaries		(2,915	)		(0.1	)		(38	)		(0.0	)		(2,877	)		7571.1
Net Income attributable to LiqTech		347,504			7.0			(903,956	)		(30.6	)		1,251,460			(138.4	)

24

	Nine Months Period ended September 30,
													Period to period change
	2014			As a % of Sales			2013			As a % of Sales			US$			Percent %
Net Sales		12,102,595			100	%		9,154,674			100	%		2,947,921			32.2
Cost of Goods Sold		9,229,131			76.3			8,025,657			87.7			1,203,474			15.0
Gross Profit		2,873,464			23.7			1,129,017			12.3			1,744,447			154.5
Operating Expenses
Selling and Marketing		2,430,814			20.1			1,943,522			21.2			487,292			25.1
General and Administrative		2,174,942			18.0			1,773,073			19.4			401,869			22.7
Non-cash compensation		372,960			3.1			1,051,857			11.5			(678,897	)		(64.5	)
Research and Development		223,532			1.8			350,515			3.8			(126,983	)		(36.2	)
Total Operating Expenses		5,202,248			43.0			5,118,967			55.9			83,281			1.6
Income (loss) from Operating		(2,328,784	)		(19.2	)		(3,989,950	)		(43.6	)		1,661,166			(41.6	)
Interest and Other Income		29,777			0.2			11,713			0.1			18,064			154.2
Interest (Expense)		(40,914	)		(0.3	)		(39,038	)		(0.4	)		(1,876	)		4.8
(Loss) on Investments		(832	)		(0.0	)		0			0.0			(832	)	-
Gain (loss) on Currency Transactions		192,226			1.6			78,037			0.9			114,189			146.3
Gain (Loss) on Sale of Fixed Assets		-			-			(2,135	)		0.0			2,135			(100.0	)
Total Other Income (Expense)		180,257			1.5			48,577			0.5			131,680			271.1
Income Before Income Taxes		(2,148,527	)		(17.8	)		(3,941,373	)		(43.1	)		1,792,846			(45.5	)
Income Taxes Expense (Income)		(972,430	)		(8.0	)		-1,045,307			(11.4	)		72,877			(7.0	)
Net Income		(1,176,097	)		(9.7	)		(2,896,066	)		(31.6	)		1,719,969			(59.4	)
Less net income attributable to the non-controlled interest in subsidiaries		(6,029	)		(0.0	)		(14,197	)		(0.2	)		8,168			(57.5	)
Net Income attributable to LiqTech		(1,170,068	)		(9.7	)		(2,881,869	)		(31.5	)		1,711,801			(59.4	)

Comparison of the three month periods ended September 30, 2014 and September 30, 2013

Revenues 

Net sales for the three months ended September 30, 2014 were $4,931,406 compared to $2,949,605 for the same period in 2013, representing an increase of $1,981,801 or 67.2%. The increase in sales consist of an increase in sales of DPFs of $132,639 and an increase in sales of liquid filters and systems of $1,815,840 and an increase in sales of kiln furniture of $33,323. The increase in demand for our DPFs is mainly due to an increase in activities and mandates. The increase in demand for our liquid filters and systems is due to an increase in worldwide sales of those products and the acquisition of Provital Solutions A/S. The increase in demand for our kiln furniture is due to a decision to sell the product to a single customer this quarter while the Company had decided not to focus on the product line anymore. 

Gross Profit

Gross profit for the three months ended September 30, 2014 was $1,467,122 compared to $274,473 for same period in 2013, representing an increase of $1,192,649 or 434.5%. The increase in gross profit was due to acquisition of Provital Solution AS’ higher margin sales and an increase in our sales and a continuing focus on lowering our production costs. Included in gross profit is depreciation of $388,327 and $443,298 for the three months ended September 30, 2014 and 2013, respectively.

Expenses

Total operating expenses for the three months ended September 30, 2014 were $1,634,201 representing an increase of $42,007 or 2.6%, compared to $1,592,194 for the same period in 2013. This increase in operating expenses is attributable to an increase in selling and marketing expenses of $177,985 or 27.2%, an increase in general and administrative expenses of $169,817 or 29.8%, a decrease in non-cash compensation expenses of $296,632 or 107.1% and a decrease in research and development expenses of $9,163 or 9.9% compared to the same period in 2013.

25

Selling expenses for the three months ended September 30, 2014 were $831,990 compared to $654,005 for the same period in 2013, representing an increase of $177,985 or 27.2% and the incorporation of Provital Solutions AS for the period July 29 to September 30, 2014. This increase is attributable to an increase in costs in general, the increase in investment in our sales resources and investment in new market opportunities. While we believe that increased investment in sales may produce attractive returns for the Company, profitability from such investments will likely take several fiscal quarters to be realized.

General and administrative expenses for the three months ended September 30, 2014 were $738,761 compared to $568,944 for the same period in 2013, representing an increase of $169,817, or 29.8%. This increase is attributable to increases in general costs, increase in the provision for bad debt of $24,000, a general increase in listing expenses and the incorporation of Provital Solutions AS for the period July 29 to September 30, 2014.

Non-cash compensation expenses for the three months ended September 30, 2014 were a positive adjustment of $19,663 compared to $276,969 for the same period in 2013, representing a decrease of $296,632 or 107.1%. This decrease is attributable to the forfeiture of non vested options from the Company’s former CEO offset against non-cash compensation expense for estimated vesting of options, shares and warrants issued for services performed by directors, employees and management.

The following is a summary of our non-cash compensation: 

	For the three Months Ended
	September 30,			September 30,
	2014			2013
Compensation upon vesting of stock options granted to employees and the board of directors	$	(126,330	)	$	63,347
Compensation for vesting of restricted stock awards issued to the board of directors		106,667			154,222
Value of stock granted for services		-			-
Warrants		-			59,400
Total Non-Cash Compensation	$	(19,663	)	$	276,969

Research and development expenses for the three months ended September 30, 2014 were $83,113 compared to $92,276 for the same period in 2013, representing a decrease of $9,163, or 9.9%. This decrease is attributable to decreased research and development expenditures for the three months ending September 30, 2014 compared to the same period in 2013.

Net Income Attributable to the Company

Net income attributable to the Company for the three months ended September 30, 2014 was a profit of $347,504 compared to a loss of $903,956 for the comparable period in 2013, representing a decrease in loss of $1,251,460. This decrease was primarily attributable to an increase in gross profit of $1,192,649.  

Comparison of the nine month periods ended September 30, 2014 and September 30, 2013

Revenues 

Net sales for the nine months ended September 30, 2014 were $12,102,595 compared to $9,154,674 for the same period in 2013, representing an increase of $2,947,921 or 32.2%. The increase in sales consist of an increase in sales of DPFs of $282,879 and an increase in sales of liquid filters of $2,959,644 and a decrease in sales of kiln furniture of $290,601. The increase in demand for our DPFs is mainly due to an increase in activities and mandates. The increase in demand for our liquid filters is due to an increase in worldwide sales of those products and our acquisition of Provital Solutions A/S. The decrease in demand for our kiln furniture is due to a decision of not focusing on this product line.

Gross Profit

Gross profit for the nine months ended September 30, 2014 was $2,873,464 compared to $1,129,017 for same period in 2013, representing an increase of $1,744,447 or 154.5%. The increase in gross profit was due to an increase in our sales and a continuing focus on lowering our production costs. Furthermore the acquisition of Provital Solutions A/S has had a positive impact on the gross profit. Included in the gross profit is depreciation of $1,264,536 and $1,220,264 for the nine months ended September 30, 2014 and 2013, respectively.

Expenses

Total operating expenses for the nine months ended September 30, 2014 were $5,202,248 representing an increase of $83,281 or 1.6%, compared to $5,118,967 for the same period in 2013. This increase in operating expenses is attributable to an increase in selling and marketing expenses of $487,292 or 25.1%, an increase in general and administrative expenses of $401,869 or 22.7%, a decrease in non-cash compensation expenses of $678,897 or 64.5% and a decrease in research and development expenses of $126,983 or 36.2% compared to the same period in 2013.

26

Selling expenses for the nine months ended September 30, 2014 were $2,430,814 compared to $1,943,522 for the same period in 2013, representing an increase of $487,292 or 25.1%. This increase is attributable to an increase in costs in general, the increase in investment in our sales resources and investment in new market opportunities. While we believe that increased investment in sales may produce attractive returns for the Company, profitability from such investments will likely take several fiscal quarters to be realized.

General and administrative expenses for the nine months ended September 30, 2014 were $2,174,942 compared to $1,773,073 for the same period in 2013, representing an increase of $401,869, or 22.7%. This increase is attributable to increases in general costs, increase in the provision for bad debt of $85,686 and a general increase in listing expenses especially because of our acquisition of Provital Solution AS.

Non-cash compensation expenses for nine months ended September 30, 2014 were $372,960 compared to $1,051,857 for the same period in 2013, representing a decrease of $678,897 or 64.5%. This decrease is attributable to decreased non-cash compensation expense for options, shares and warrants for services performed granted to directors, employees and management.

The following is a summary of our non-cash compensation: 

	For the nine Months Ended
	September 30,			September 30,
	2014			2013
Compensation upon vesting of stock options granted to employees and the board of directors	$	(6,439	)	$	328,613
Compensation for vesting of restricted stock awards issued to the board of directors		319,999			284,444
Value of stock granted for services		-			320,000
Warrants		59,400			118,800
Total Non-Cash Compensation	$	(372,960	)	$	1,051,857

Research and development expenses for the nine months ended September 30, 2014 were $223,532 compared to $350,515 for the same period in 2013, representing a decrease of $126,983, or 36.2%. This decrease is attributable to decreased research and development expenditures for the nine months ending September 30, 2014 compared to the same period in 2013.

Net Loss Attributable to the Company

Net income attributable to the Company for the nine months ended September 30, 2014 was a loss of $1,170,068 compared to a loss of $2,881,869 for the comparable period in 2013, representing a decrease in loss of $1,711,801. This decrease was primarily attributable to an increase of $1,744,447 in gross profit.  

Liquidity and Capital Resources

We have historically satisfied our capital and liquidity requirements through offerings of equity instruments, internally generated cash from operations and our available lines of credit. At September 30, 2014, we had cash of $6,736,113 and working capital of $13,850,428 and at December 31, 2013, we had cash of $4,884,275 and working capital of $7,692,669. At September 30, 2014, our working capital increased by $6,157,759 compared to December 31, 2013. Total current assets were $17,487,560 and $12,239,110 at September 30, 2014 and at December 31, 2013, respectively, and total current liabilities were $3,637,132 and $4,546,441 at September 30, 2014 and at December 31, 2013, respectively.

On July 28, 2014, we closed a public offering of 8,000,000 shares at a price to public of $1.50 per share, which included all 1,043,478 shares subject to the underwriter’s over-allotment option. Net proceeds received from the offering were approximately $10.8 million, after deducting underwriting discounts and offering expenses. The Company used approximately $2.3 million of the offering to fund a portion of the purchase price of Provital and the balance shall be used to pay transaction expenses and for other general corporate purposes.

On October 9, 2013, we announced that the warrant and option exercise raised $4,051,000 which included the exercise of 100,000 warrants by Aldo Petersen, Chairman of the Board of LiqTech, 25,000 stock options by Lasse Andreassen, founder and former Board member of LiqTech and 50,000 stock options by Soren Degn, CFO of LiqTech, $450,000 was received on September 30, 2013 and $3,601,000 was received during October 2013. The Board noted that the additional capital was an orderly solution to improving the Company's capital structure as well as enhancing the ability of LiqTech to list on an exchange. In addition, the new capital gives the Company additional flexibility to generate new orders and to sustain future growth.

27

On March 2, 2012, we completed a registered public offering of our common stock. As part of the initial closing, we issued 2,511,500 shares of our common stock in a registered direct placement of our shares at a per share price of $3.25. The net proceeds to us from the initial closing were approximately $7.1 million.

Provital Solutions AS has a DKK 2,000,000 (approximately $340,000 at September 30, 2014) standby line of credit with a bank, subject to certain borrowing base limitations. Outstanding borrowings are due on demand. Interest is calculated based on a variable interest rate and is payable quarterly. As of September 30, 2014, the interest on this line of credit was at 3.50%. This line of credit is guaranteed by Vækstfonden (the Danish state's investments fund) and is also secured by certain of Provital Solutions AS’s assets like receivables, inventory, equipment etc. There was $2,406 outstanding as of September 30, 2014. At September 30, 2014, there was approximately $335,000 available under this credit line. In general, lines of credit in Denmark are due on demand. We do not believe that any of our lines of credit will be called, but if they were called, we believe that we could refinance with other lenders in Denmark with similar terms.

In connection with some orders, we have to give the customer a working guarantee or a prepayment guarantee or similar. For that purpose, we have a credit line of DKK 5,000,000 (approximately $845,000 at September 30, 2014) with a bank, subject to certain base limitations.

We believe that our cash flow and other potential sources of funds will be sufficient to fund our anticipated working capital needs and capital spending requirements for the foreseeable future. However, if we were to incur any unanticipated expenditures or the negative trend of our operating cash flow does continue, such circumstances could put a substantial burden on our cash resources.

We may also need additional funds for possible future strategic acquisitions of businesses, products or technologies complementary to our business. If additional funds are required, we may raise such funds from time to time through public or private sales of equity or debt securities. Financing may not be available on acceptable terms, or at all, and our failure to raise capital when needed could materially adversely impact our growth plans and our financial condition and results of operations. Additional equity financing may be dilutive to holders of our common stock, and debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate our business.

Cash Flows

Nine months ended September 30, 2014 Compared to nine months ended September 30, 2013

Cash provided (used) by operating activities is net income (losses) adjusted for certain non-cash items and changes in assets and liabilities. Cash used by operating activities for the nine months ended September 30, 2014 was $3,708,770, representing an increase of $1,476,356 compared to cash used by operating activities of $2,232,414 for the nine months ended September 30, 2013. The $1,476,356 increase in cash used by operating activities for the nine months ended September 30, 2014 was mainly due to the decreases of $1,146,846 in accounts payable, accrued expenses of $2,211,334, and a decrease of $438,682 in long-term contracts.

The increases in accounts payable, accrued expenses and the decrease in long-term contracts were all due to normal variations in the ordinary course of business.

Cash used in investing activities was $2,065,124 for the nine months period ended September 30, 2014, as compared to cash used in investing activities of $415,645 for the nine months period ended September 30, 2013. Cash used in investing activities increased for the nine months period ended September 30, 2014, compared to the nine months period ended September 30, 2013. This increase was primarily due to the net cash of $1,874,684 used in the acquisition of Provital Solutions AS, offset by a period over period decrease of $202,115 in the purchase of property and equipment.

Cash provided by financing activities was $8,854,104 for the nine months period ended September 30, 2014, as compared to cash provided by financing activities of $317,856 for the nine months period ended September 30, 2013. This change of $8,536,248 in cash provided by financing activities for the nine months period ended September 30, 2014 compared to 2013, was due to the public offering of 8,000,000 shares at a price to public of $1.50 per share,. 

Off Balance Sheet Arrangements

As of September 30, 2014, we had no off-balance sheet arrangements other than normal operating leases. We are not aware of any material transactions which are not disclosed in our consolidated financial statements.

Operating Leases-- The Company leases office and production facilities under operating lease agreements expiring in August 2018, March 2017, February 2017, June 2017, December 2016 and June 2016. In some of these lease agreements, the Company has the right to extend.

28

The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of one year as of September 30, 2014 are as follows:

Year ending December	Operating Lease Payments
2014	$	169,334
2015		695,240
2016		693,791
2017		482,503
2018		287,962
Thereafter		-
Total Minimum Lease Payments	$	2,328,830

Significant Accounting Policies and Critical Accounting Estimates

There have been no significant changes in our significant accounting policies and critical accounting estimates since the filing of our Annual Report on Form 10-K for the period ended December 31, 2013.

Recent Enacted Accounting Standards

For a description of accounting changes and recent accounting standards, including the expected dates of adoption and estimated effects, if any, on our consolidated financial statements, see “Note 1: Recently Enacted Accounting Standards” in the accompanying Financial Statements.

Off Balance Sheet Arrangements

We are not aware of any material transactions which are not disclosed in our consolidated financial statements.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4.  CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Our management, under supervision and with the participation of both of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 (the “Exchange Act”) Rules 13a-15(e) and 15-d-15(e)) as of the end of the period covered by this report (the “Evaluation Date”). Based upon that evaluation, both of our Chief Executive Officer and Chief Financial Officer concluded that as of the Evaluation Date, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.　

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal controls over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1A. RISK FACTORS.

Not required for a “smaller reporting company.”

29

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

None.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

1.1	Placement Agency Agreement, dated March 2, 2012, by and between LiqTech International, Inc. and Sunrise Securities Corp.	Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on March 8, 2012
2.1	Agreement and Plan of Merger dated as of August 23, 2011 by and among Blue Moose Media, Inc., LiqTech USA, Inc. and BMD Sub	Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K/A as filed with the SEC on October 11, 2011
3.1	Articles of Incorporation	Incorporated by reference to Exhibit 3(i) to the Company’s Registration Statement on Form 10 (SEC Accession No. 0001078782-09-001287) as filed with the SEC on August 19, 2009
3.2	Certificate of Amendment to the Articles of Incorporation	Incorporated by reference to Exhibit A to the Company’s Information Statement on Schedule 14C as filed with the SEC on September 20, 2011
3.3	Amended and Restated Bylaws, effective January 1, 2012	Incorporated by reference to Exhibit 3.4 to the Company’s Form 10-Q as filed with the SEC on May 15, 2012
4.1	Form of Common Stock Certificate	Incorporated by reference to Exhibit 4.1 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
4.2	Form of Warrant issued to Investors in the Private Placement	Incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K as filed with the SEC on August 25, 2011

30

4.3	Form of Warrant issued to Sunrise Securities Corp.	Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K as filed with the SEC on March 8, 2012
10.1	Form of Securities Purchase Agreement by and between LiqTech USA, Inc. and each of the investors in the Private Placement	Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on August 25, 2011
10.2	Employment Agreement dated July 29, 2011 between LiqTech A/S and Lasse Andreassen	Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K/A as filed with the SEC on October 11, 2011 (translated in English)
10.3	Employment Agreement dated November 16, 2005 between LiqTech NA, Inc. and Donald S. Debelak	Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K/A as filed with the SEC on October 11, 2011
10.4	Addendum to Employment Agreement, dated December 15, 2011, between LiqTech NA, Inc. and Donald S. Debelak	Incorporated by reference to Exhibit 10.4 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.5	Employment Agreement, dated July 29, 2011, between LiqTech International Inc. and Soren Degn (translated in English)	Incorporated by reference to Exhibit 10.5 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.6	Lease Agreements for 1800 - 1810 Buerkle Road, White Bear Lake, Minnesota 55110	Incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011
10.7	Lease Agreement for 1800 - 1816 Buerkle Road, White Bear Lake, Minnesota 55110	Incorporated by reference to Exhibit 10.7 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.8	Lease Agreement for Grusbakken 12, DK-2820 Gentofte Denmark	Incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)

31

10.9	Lease Agreement for Industriparken 22C, 2750 Ballerup, Denmark	Incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)
10.10	DKK 6,000,000 Line of Credit Agreement, between LiqTech A/S and Sydbank A/S	Incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)
10.11	DKK 3,000,000 Line of Credit Agreement, between LiqTech A/S and Sydbank A/S	Incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)
10.12	Note Payable Agreement between LiqTech A/S and Sydbank A/S, for the principal amount of $475,000 USD	Incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q as filed with the SEC on November 15, 2011 (translated in English)
10.13	Form of Guarantee in respect of obligations of LiqTech A/S (translated in English)	Incorporated by reference to Exhibit 10.13 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.14	Form of Guarantee in respect of obligations of LiqTech International A/S (translated in English)	Incorporated by reference to Exhibit 10.14 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.15	Form of Guarantee in respect of obligations of LiqTech NA, Inc. (translated in English)	Incorporated by reference to Exhibit 10.15 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.16	Form of Promissory Note payable to certain related parties	Incorporated by reference to Exhibit 10.16 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

32

10.17	Business Mortgage of LiqTech A/S (translated in English)	Incorporated by reference to Exhibit 10.17 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.18	Business Mortgage of LiqTech International A/S (translated in English)	Incorporated by reference to Exhibit 10.18 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
10.19	Bonus and Services Agreement, dated October 31, 2012, by and between the Company and Aldo Petersen	Incorporated by reference to Exhibit 10.19 to the Company’s Quarterly Report on Form 10-Q as filed with the SEC on November 14, 2012
10.20	Agreement, dated March 25, 2013, by and among LiqTech International, Inc., LiqTech Denmark International and Mr. Lasse Andreassen	Incorporated by reference to Exhibit 10.20 to the Company’s Form 10-K as filed with the SEC on March 27, 2013
10.21	Director Contract, dated March 27, 2013, by and between Mr. Finn Helmer and LiqTech Denmark International	Incorporated by reference to the Company's Form 10-Q as filed with the SEC on May 15, 2013
10.22	Securities Purchase Agreement, dated July 15, 2014 by and among LiqTech International A/S, a Danish company, Provital Solutions A/S, a Danish company and Masu A/S, a Danish company	Incorporated by reference to the Company’s Form 8-K as filed with the SEC on July 16, 2014
10.23	Form of Purchase Agreement (Craig-Hallum Capital Group LLC)	Incorporated by reference to the Company’s Form 8-K as filed with the SEC on July 23, 2014
10.24	Form of Underwriter’s Warrant (Craig-Hallum Capital Group LLC)	Incorporated by reference to the Company’s Form 8-K as filed with the SEC on July 23, 2014
10.25	Employment Contract (Sune Mathiesen)	Incorporated by reference to the Company’s Form 8-K as filed with the SEC on August 1, 2014

33

21	List of Subsidiaries	Incorporated by reference to Exhibit 21 to the Company’s Form 10-K as filed with the SEC on March 29, 2012
31.1	Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Provided herewith
31.2	Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Provided herewith
32.1	Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002	Furnished, not filed herewith
32.2	Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002	Furnished, not filed herewith
101. INS	XBRL Instance Document	Provided herewith
101. CAL	XBRL Taxonomy Extension Calculation Link base Document	Provided herewith
101. DEF	XBRL Taxonomy Extension Definition Link base Document	Provided herewith
101. LAB	XBRL Taxonomy Label Link base Document	Provided herewith
101. PRE	XBRL Extension Presentation Link base Document	Provided herewith
101. SCH	XBRL Taxonomy Extension Scheme Document	Provided herewith

34

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized,

	LiqTech International, Inc.
Dated: November 13, 2014	/s/ Sune Mathiesen
	Sune Mathiesen, Chief Executive Officer
	(Principal Executive Officer)
Dated: November 13, 2014	/s/ Soren Degn
	Soren Degn, Chief Financial Officer
	(Principal Financial and Accounting Officer)

35

EX-31

EXHIBIT 31.1

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

I, Sune Mathiesen, certify that:

1.            I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2014 of Liqtech International, Inc.;

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)         Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.            The registrant’s other certifying officer (s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2014	By:	/s/ Sune Mathiesen
	Name:	Sune Mathiesen
	Title:	Chief Executive Officer and Principal Executive Officer

EX-31

EXHIBIT 31.2

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

I, Soren Degn, certify that:

1.            I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2014 of Liqtech International, Inc.;

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)         Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.            The registrant’s other certifying officer (s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2014	By:	/s/ Soren Degn
	Name:	Soren Degn
	Title:	Chief Financial Officer and Principal Financial and Accounting Officer

EX-32

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Liqtech International, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2014 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “ Report ”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: November 13, 2014	By:	/s/ Sune Mathiesen
	Name:	Sune Mathiesen
	Title:	Chief Executive Officer and Principal Executive Officer

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.

EX-32

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Liqtech International, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2014 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “ Report ”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: November 13, 2014	By:	/s/ Soren Degn
	Name:	Soren Degn
	Title:	Chief Financial Officer and Principal Financial and Accounting Officer

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.

XML

Note 4 - Investments (Details) - Summary of Level 1-3 Financial Assets and Liabilities (USD $)	Sep. 30, 2014	Dec. 31, 2013
Fair Value, Inputs, Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments	$ 0	$ 0
Total	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments	0	0
Total	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments	6,297	6,882
Total	$ 6,297	$ 6,882

XML

Note 10 - Earnings Per Share (Details) - Amounts Used in Computing Earnings Per Share (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Amounts Used in Computing Earnings Per Share [Abstract]
Income (Loss) attributable to LiqTech International Inc. (in Dollars)	$ 347,504	$ (903,956)	$ (1,170,068)	$ (2,881,869)
Weighted average number of common shares used in basic earnings per share	35,613,164	24,511,500	30,043,493	24,329,082
Effect of dilutive securities, stock options and warrants	0	0	0	0
Weighted average number of common shares and potentially dilutive securities	36,034,570	24,511,500	30,043,493	24,329,082

XML

Note 8 - Agreements and Commitments (Details)	9 Months Ended
	Sep. 30, 2014 USD ($)	Sep. 30, 2013 USD ($)	Sep. 30, 2014 DKK
Disclosure Text Block Supplement [Abstract]
Defined Contribution Plan, Cost Recognized	$ 12,110	$ 11,902
Line of Credit Facility, Maximum Borrowing Capacity	845,000		5,000,000
Guarantor Obligations, Current Carrying Value	$ 230,000		1,379,646

XML

Note 11 - Stockholders' Equity (Details) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended	0 Months Ended		9 Months Ended			12 Months Ended	9 Months Ended				1 Months Ended	12 Months Ended	0 Months Ended				1 Months Ended
	Oct. 09, 2013	Jul. 28, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Oct. 09, 2013 Warrant [Member] Board of Directors Chairman [Member]	Oct. 09, 2013 Warrant [Member]	Sep. 30, 2014 Warrant [Member]	Sep. 30, 2014 Restricted Stock [Member] Director [Member]	Sep. 30, 2014 Restricted Stock [Member]	Dec. 31, 2013 Restricted Stock [Member]	Sep. 30, 2014 Employee Stock Option [Member] 2011 Stock Options Plan [Member]	Sep. 30, 2013 Employee Stock Option [Member] 2011 Stock Options Plan [Member]	Sep. 30, 2014 Employee Stock Option [Member]	Sep. 30, 2013 Employee Stock Option [Member]	Jul. 29, 2014 Provital Acquisition [Member]	Dec. 31, 2013 Director [Member]	Oct. 09, 2013 Founder and Board Member [Member]	Oct. 09, 2013 Chief Financial Officer [Member]	Sep. 30, 2014 2011 Stock Options Plan [Member]	Jun. 30, 2014 2011 Stock Options Plan [Member]	Jul. 28, 2014 Craig-Hallum Capital Group LLC [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Shares Authorized			100,000,000		100,000,000		100,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)			$ 0.001		$ 0.001		$ 0.001
Common Stock, Shares, Issued			39,304,782		39,304,782		27,212,500
Common Stock, Shares, Outstanding			39,304,782		39,304,782		27,212,500
Stock Issued During Period, Shares, New Issues		8,000,000
Share Price (in Dollars per share)		$ 1.50
Proceeds from Issuance of Common Stock (in Dollars)		$ 10,800,000
Payments of Stock Issuance Costs (in Dollars)		1,149,096			1,149,096
Stock Issued During Period, Shares, Acquisitions																		4,044,782
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			47,500		47,500															25,000	50,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)			$ 1.50		$ 1.50
Stock Issued During Period, Shares, Issued for Services							100,000
Stock Issued During Period, Value, Issued for Services (in Dollars)							320,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross																			300,000
Stock Issued During Period, Value, Restricted Stock Award, Gross (in Dollars)																			960,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period													133,333
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Remainder of Fiscal Year												133,333
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Next Twelve Months												33,334
Deferred Compensation Share-based Arrangements, Liability, Current (in Dollars)											320,001
Allocated Share-based Compensation Expense (in Dollars)			(19,663)	276,969	372,960	1,051,857				59,400	320,000			(6,439)	613,057	372,960	1,051,857
Proceeds from Warrants and Stock Options Exercised (in Dollars)	4,051,000
Share-based Compensation Arrangement by Share-based Payment Award, Warrants and Options, Exercises in Period (in Dollars)	2,701,000
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised								100,000	2,626,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number										0
Proceeds from Issuance of Warrants (in Dollars)																								50
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right																								400,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 2.70																							$ 1.65
Warrants, Term																								5 years
Warrants Not Settleable in Cash, Fair Value Disclosure (in Dollars)	1,124,928
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number			2,416,630		2,416,630		2,564,130			7,425,575													2,416,630
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)			313,233		313,233																	313,233
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares			333,333		333,333
Share-based Compensation Arrangements by Share-based Payment Award, Options, Non-vested, Weighted Average Exercise Price (in Dollars per share)					$ 1.90
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value (in Dollars per share)			$ 0.805		$ 0.805
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition																2 years 120 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)			$ 13,200		$ 13,200		$ 283,125

XML

Note 7 - Leases (Details) - Future Minimum Lease Payments for Non-Cancelable Operating Leases (USD $)	Sep. 30, 2014
Future Minimum Lease Payments for Non-Cancelable Operating Leases [Abstract]
2014	$ 169,334
2015	695,240
2016	693,791
2017	482,503
2018	287,962
Thereafter	0
Total Minimum Lease Payments	$ 2,328,830

XML

Note 1 - Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		9 Months Ended			9 Months Ended		12 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2014 LiqTech International DK [Member]	Sep. 30, 2014 LiqTech NA [Member]	Dec. 30, 2013 LiqTech NA [Member]	Sep. 30, 2014 LiqTech Asia [Member]	Sep. 30, 2014 LiqTech Germany [Member]	Sep. 30, 2014 LiqTech PTE [Member]	Sep. 30, 2014 Employee Stock Option [Member]	Sep. 30, 2013 Employee Stock Option [Member]	Sep. 30, 2014 Minimum [Member]	Sep. 30, 2014 Maximum [Member]	Sep. 30, 2014 DENMARK
Note 1 - Summary of Significant Accounting Policies (Details) [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage						100.00%	100.00%	90.00%	60.00%	100.00%	95.00%
Percentage of Subsidiary Owned by Subsidiary of Parent								10.00%
Cash, Uninsured Amount	$ 0		$ 0		$ 0
Property, Plant and Equipment, Useful Life														3 years	10 years
Finite-Lived Intangible Asset, Useful Life														2 years	10 years
Value Added Tax of Invoice, Percentage																25.00%
Advertising Expense			17,120	30,556
Research and Development Expense	83,113	92,276	223,532	350,515
Allocated Share-based Compensation Expense	(19,663)	276,969	372,960	1,051,857								372,960	1,051,857
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense												$ 0	$ 0

XML

Note 11 - Stockholders' Equity (Details) - Assumptions Used to Calculate the Fair Values of Stock Options	9 Months Ended
	Sep. 30, 2014
Note 11 - Stockholders' Equity (Details) - Assumptions Used to Calculate the Fair Values of Stock Options [Line Items]
Volatility	40.74%
Risk free interest rate	0.67%
Dividend yield	0.00%
Minimum [Member]
Note 11 - Stockholders' Equity (Details) - Assumptions Used to Calculate the Fair Values of Stock Options [Line Items]
Expected term (in years)	3 years
Maximum [Member]
Note 11 - Stockholders' Equity (Details) - Assumptions Used to Calculate the Fair Values of Stock Options [Line Items]
Expected term (in years)	4 years

XML

Note 4 - Investments (Tables)

9 Months Ended

Sep. 30, 2014

Investments, Debt and Equity Securities [Abstract]

Fair Value, by Balance Sheet Grouping [Table Text Block]

As of September 30, 2014	Level 1		Level 2		Level 3
Investments		-		-		6,297
Total		-		-		6,297

As of December 31, 2013	Level 1		Level 2		Level 3
Investments		-		-		6,882
Total		-		-		6,882

XML

Note 9 - Income Taxes (Details) - Deferred Tax Asset (Liabilities) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Deferred Tax Asset (Liabilities) [Abstract]
Vacation accrual	$ 4,161	$ 4,161
Allowance for doubtful Accounts	31,566	13,955
Long term contracts	13,036	0
Reserve for obsolete inventory	85,164	86,027
Net current tax assets	133,927	104,143
Business tax credit carryover	20,184	20,184
Deferred compensation	202,309	202,309
Net operating loss carryover	3,525,333	2,367,568
Excess of book over tax depreciation	(725,134)	(726,712)
Long term deferred tax asset	$ 3,022,692	$ 1,863,349

XML

Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) - Summary of Goodwill (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Summary of Goodwill [Abstract]
Goodwill at beginning of period	$ 0	$ 0
Goodwill resulting from the Provital acquisition	8,547,540	0
Effect of currency translation	(567,213)	0
Goodwill at end of period	$ 7,980,327	$ 0

XML

Note 3 - Property and Equipment (Details) - Property and Equipment (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property and equipment	$ 12,796,971	$ 13,166,180
Less Accumulated Depreciation	(7,940,014)	(7,336,776)
Net Property and Equipment	4,856,957	5,829,404
Production Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Production Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	10 years
Production Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	11,045,097	11,542,740
Lab Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Lab Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	10 years
Lab Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	166,019	181,432
Computer Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Computer Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	5 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	300,837	276,013
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Property and equipment	99,151	38,221
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful life	5 years
Property and equipment	136,101	68,169
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful life	10 years
Property and equipment	$ 1,049,766	$ 1,059,605
Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	10 years

XML

Note 9 - Income Taxes (Details) - Components of Income Tax Expense (Benefit) from Continuing Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Note 9 - Income Taxes (Details) - Components of Income Tax Expense (Benefit) from Continuing Operations [Line Items]
Federal			$ 0	$ 0
State			0	0
Current tax expense			1,020	0
Net operating loss carryover			(973,450)	(1,032,389)
Allowance for doubtful accounts			0	0
Reserve for obsolete inventory			0	(12,918)
Deferred tax expense			(973,450)	(1,045,307)
Income tax benefit	(276,870)	(303,784)	(972,430)	(1,045,307)
Danish Ministry of Taxation [Member]
Note 9 - Income Taxes (Details) - Components of Income Tax Expense (Benefit) from Continuing Operations [Line Items]
Foreign current income tax expense (benefit)			0	0
National Tax Service [Member]
Note 9 - Income Taxes (Details) - Components of Income Tax Expense (Benefit) from Continuing Operations [Line Items]
Foreign current income tax expense (benefit)			$ 1,020	$ 0

XML

Note 12 - Significant Customers / Concentration (Details) - Sales by Product Line (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting, Revenue Reconciling Item [Line Items]
Net sales	$ 4,931,406	$ 2,949,605	$ 12,102,595	$ 9,154,674
Ceramic Diesel Particulate [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net sales	1,519,204	1,386,565	5,137,720	4,858,841
Liquid Filters [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net sales	3,256,689	1,440,849	6,639,362	3,679,719
Kiln Furniture [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net sales	$ 155,513	$ 122,191	$ 325,513	$ 616,114

XML

Note 7 - Leases (Details) - Future Minimum Capital Lease Payments (USD $)	Sep. 30, 2014	Dec. 31, 2013
Future Minimum Capital Lease Payments [Abstract]
2014	$ 70,077
2015	223,548
2016	216,916
2017	145,029
2018	28,282
Thereafter	0
Total minimum lease payments	683,852
Less amount representing interest	(65,669)
Present value of minimum lease payments	618,183
Less current portion	(181,595)	(208,419)
Long-term lease payments	$ 436,588	$ 554,360

XML

Note 3 - Property and Equipment

9 Months Ended

Sep. 30, 2014

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

NOTE 3 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at September 30, 2014 and December 31, 2013:

	Useful Life		2014			2013
Production equipment		3 - 10	$	11,045,097		$	11,542,740
Lab equipment		3 - 10		166,019			181,432
Computer equipment		3 - 5		300,837			276,013
Vehicles		3		99,151			38,221
Furniture and fixture		5		136,101			68,169
Leasehold improvements		10		1,049,766			1,059,605
				12,796,971			13,166,180
Less Accumulated Depreciation				(7,940,014	)		(7,336,776	)
Net Property and Equipment			$	4,856,957		$	5,829,404

Depreciation expense amounted to $1,258,479 and $1,216,745, for the nine months ended September 30, 2014 and 2013, respectively. 

XML

Note 13 - Acquisition (Details)				1 Months Ended																37 Months Ended
	Sep. 30, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)	Jul. 29, 2014 Scenario 1 for Year Ending December 31, 2014 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Scenario 1 for Year Ending December 31, 2014 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 Scenario 2 for Year Ending December 31, 2014 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Scenario 2 for Year Ending December 31, 2014 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 Scenario 1 For the Year Ending December 31, 2015 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Scenario 1 For the Year Ending December 31, 2015 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 Scenario 2 For the Year Ending December 31, 2015 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Scenario 2 For the Year Ending December 31, 2015 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 Scenario 1 for Years Ending December 31, 2014 and December 31, 2015 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Scenario 1 for Years Ending December 31, 2014 and December 31, 2015 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 Scenario 2 for Years Ending December 31, 2014 and December 31, 2015 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Scenario 2 for Years Ending December 31, 2014 and December 31, 2015 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 For Year Ending December 31, 2016 [Member] Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 For Year Ending December 31, 2016 [Member] Provital Solutions AS [Member] DKK	Jul. 29, 2014 Provital Solutions AS [Member] USD ($)	Jul. 29, 2014 Provital Solutions AS [Member] DKK	Jul. 29, 2017 Provital Solutions AS [Member] USD ($)	Sep. 30, 2014 Provital Solutions AS [Member] USD ($)
Note 13 - Acquisition (Details) [Line Items]
Payments to Acquire Businesses, Gross																		$ 2,300,000	12,600,000	$ 2,300,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)																		4,044,782	4,044,782	4,044,782
Business Acquisition, Requirement for Minimum Revenues				10,988,639	65,000,000	8,452,800	50,000,000	20,286,719	120,000,000	13,524,479	80,000,000
Business Acquisition, Requirement for EBITDA				1,098,864	6,500,000	1,690,560	10,000,000	2,028,672	12,000,000	2,704,896	16,000,000
Business Acquisition, "Catch Up" Provisions, Minimum Revenues												31,275,358	185,000,000	21,977,279	130,000,000	17,750,879	105,000,000
Business Acquisition, “Catch Up” Provisions, Minimum EBITDA												3,127,536	18,500,000	4,395,456	26,000,000	3,550,176	21,000,000
Goodwill	$ 7,980,327	$ 0	$ 0															$ 8,547,540			$ 7,980,327

XML

Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) - Goodwill (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2014 Provital Solutions AS [Member]	Jul. 29, 2014 Provital Solutions AS [Member]
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) - Goodwill [Line Items]
Goodwill	$ 7,980,327	$ 0	$ 0	$ 7,980,327	$ 8,547,540

XML

Note 10 - Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares [Table Text Block]

	For the Three Months Ended September 30					For the Nine Months Ended September 30
	2014		2013			2014			2013
Income (Loss) attributable to LiqTech International Inc.	$	347,504	$	(903,956	)	$	(1,170,068	)	$	(2,881,869	)
Weighted average number of common shares used in basic earnings per share		35,613,164		24,511,500			30,043,493			24,329,082
Effect of dilutive securities, stock options and warrants		-		-			-			-
Weighted average number of common shares and potentially dilutive securities	$	36,034,570	$	24,511,500		$	30,043,493		$	24,329,082

XML

Note 9 - Income Taxes (Tables)

9 Months Ended

Sep. 30, 2014

Income Tax Disclosure [Abstract]

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	2014			2013
Vacation accrual	$	4,161		$	4,161
Allowance for doubtful Accounts		31,566			13,955
Long term contracts		13,036			-
Reserve for obsolete inventory		85,164			86,027
Net current tax assets	$	133,927		$	104,143
Business tax credit carryover		20,184			20,184
Deferred compensation		202,309			202,309
Net operating loss carryover		3,525,333			2,367,568
Excess of book over tax depreciation		(725,134	)		(726,712	)
Long term deferred tax asset	$	3,022,692		$	1,863,349

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	2014			2013
Computed tax at expected statutory rate	$	(1,107,897	)	$	(1,335,240	)
State and local income taxes, net of federal benefits		(24,703	)		(15,743	)
Non-deductible expenses		52,174			205,498
Non-US income taxed at different rates		107,996			100,735
Other items		-			(557	)
Income tax (benefit)	$	(972,430	)	$	(1,045,307	)

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	2014			2013
Current income tax expense:
Danish	$	-		$	-
Korean		1,020			-
Federal		-			-
State		-			-
Current tax expense	$	1,020		$	-
Net operating loss carryover		(973,450	)		(1,032,389	)
Allowance for doubtful accounts		-			-
Reserve for obsolete inventory		-			(12,918	)
Deferred tax expense	$	(973,450	)	$	(1,045,307	)
Income tax benefit	$	(972,430	)	$	(1,045,307	)

XML

Note 11 - Stockholders' Equity (Details) - Warrants Outstanding (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	2,416,630	2,564,130
Warrants Weighted-average Remaining Contractual Life	292 days	1 year 233 days
Warrants Weighted-average Exercise Price	$ 2.59	$ 2.65
Warrants Exercisable (in Shares)	2,083,297
Warrants Exercisable Weighted-average Exercise Price	$ 2.70
Warrant [Member] | Price Range 1 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 1.50
Warrants Outstanding (in Shares)	3,874,000
Warrants Weighted-average Remaining Contractual Life	2 years 3 months
Warrants Weighted-average Exercise Price	$ 1.50
Warrants Exercisable (in Shares)	3,874,000
Warrants Exercisable Weighted-average Exercise Price	$ 1.50
Warrant [Member] | Price Range 2 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 1.65
Warrants Outstanding (in Shares)	400,000
Warrants Weighted-average Remaining Contractual Life	4 years 302 days
Warrants Weighted-average Exercise Price	$ 1.65
Warrants Exercisable (in Shares)	400,000
Warrants Exercisable Weighted-average Exercise Price	$ 1.65
Warrant [Member] | Price Range 3 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 2.35
Warrants Outstanding (in Shares)	400,000
Warrants Weighted-average Remaining Contractual Life	6 months
Warrants Weighted-average Exercise Price	$ 2.35
Warrants Exercisable (in Shares)	400,000
Warrants Exercisable Weighted-average Exercise Price	$ 2.35
Warrant [Member] | Price Range 4 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 2.70
Warrants Outstanding (in Shares)	2,626,000
Warrants Weighted-average Remaining Contractual Life	2 years 3 months
Warrants Weighted-average Exercise Price	$ 2.70
Warrants Exercisable (in Shares)	2,626,000
Warrants Exercisable Weighted-average Exercise Price	$ 2.70
Warrant [Member] | Price Range 5 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 4.0625
Warrants Outstanding (in Shares)	125,575
Warrants Weighted-average Remaining Contractual Life	2 years 156 days
Warrants Weighted-average Exercise Price	$ 4.0625
Warrants Exercisable (in Shares)	125,575
Warrants Exercisable Weighted-average Exercise Price	$ 4.06
Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	7,425,575
Warrants Weighted-average Remaining Contractual Life	2 years 109 days
Warrants Weighted-average Exercise Price	$ 2.02
Warrants Exercisable (in Shares)	7,425,575
Warrants Exercisable Weighted-average Exercise Price	$ 2.02
Price Range 1 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 1.50
Price Range 2 [Member]
Class of Warrant or Right [Line Items]
Warrants Range of Exercise Price	$ 1.90

XML

Note 6 - Lines of Credit (Details)	Sep. 30, 2014 USD ($)	Sep. 30, 2014 DKK	Sep. 30, 2014 Provital Solutions AS [Member] USD ($)	Sep. 30, 2014 Provital Solutions AS [Member] DKK
Note 6 - Lines of Credit (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 845,000	5,000,000	$ 340,000	2,000,000
Line of Credit Facility, Interest Rate at Period End			3.50%	3.50%
Long-term Line of Credit			2,406
Line of Credit Facility, Remaining Borrowing Capacity			335,000
Guarantor Obligations, Current Carrying Value	$ 230,000	1,379,646

XML

Note 11 - Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2014

Stockholders' Equity Note [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

		Warrants Outstanding						Warrants Exercisable
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50		3,874,000		2.25	$	1.50		3,874,000	$	1.50
$	1.65		400,000		4.83	$	1.65		400,000	$	1.65
$	2.35		400,000		0.50	$	2.35		400,000	$	2.35
$	2.70		2,626,000		2.25	$	2.70		2,626,000	$	2.70
$	4.0625		125,575		2.43	$	4.0625		125,575	$	4.06
Total			7,425,575		2.30	$	2.02		7,425,575	$	2.02

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	LiqTech International, Inc.
Expected term (in years)		3-4
Volatility		40.74
Risk free interest rate		0.67	%
Dividend yield		0	%

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

		Options Outstanding						Options Exercisable
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50		330,000		0.40	$	1.50		330,000	$	1.50
$	1.90		500,000		2.33	$	1.90		166,667	$	1.90
$	2.70		75,000		0.40	$	2.70		75,000	$	2.70
$	3.00 - 3.60		1,511,630		0.41	$	3.06		1,511,630	$	3.06
Total			2,416,630		0.80	$	2.59		2,083,297	$	2.70

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]

	September 30, 2014
	Shares			Weighted Average Exercise Price		Average Remaining Life		Weighted Average Intrinsic Value
Outstanding at beginning of period		2,564,130		$	2.65		1.64	$	283,125
Granted		500,000			1.90		2.33		-
Exercised		(47,500	)		1.50		-		-
Forfeited		(600,000	)		2.35		-		-
Expired		-			-		-		-
Outstanding at end of period		2,416,630		$	2.59		0.80	$	13,200
Vested and expected to vest		2,416,630		$	2.59		0.80	$	13,200
Exercisable end of period		2,083,297		$	2.70		0.56	$	13,200

XML

Note 12 - Significant Customers / Concentration (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2014		2013		2014		2013
United States and Canada	$	1,066,463	$	736,958	$	2,841,932	$	2,264,368
Australia		179,981		55,093		264,296		223,483
South America		-		4,679		16,845		30,058
Asia		696,102		493,542		1,191,035		1,645,025
Europe		2,988,860		1,659,333		7,788,487		4,991,740
	$	4,931,406	$	2,949,605	$	12,102,595	$	9,154,674

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2014		2013		2014		2013
Ceramic diesel particulate	$	1,519,204	$	1,386,565	$	5,137,720	$	4,858,841
Liquid filters and systems		3,256,689		1,440,849		6,639,362		3,679,719
Kiln furniture		155,513		122,191		325,513		616,114
	$	4,931,406	$	2,949,605	$	12,102,595	$	9,154,674

XML

Note 2 - Inventory

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

NOTE 2 – INVENTORY

Inventory consisted of the following at September 30, 2014 and December 31, 2013:

	2014			2013
Furnace parts and supplies	$	1,146,003		$	1,025,225
Raw materials		1,683,858			631,524
Work in process		1,585,494			1,799,888
Finished goods and filtration systems		1,090,110			1,062,865
Reserve for obsolescence		(108,454	)		(260,896	)
Net Inventory	$	5,397,011		$	4,258,606

XML

Note 13 - Acquisition (Tables)

9 Months Ended

Sep. 30, 2014

Business Combinations [Abstract]

Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]

Cash	$	2,300,000
4,044,782 common shares at $1.50 a share		6,067,173
Current consideration transferred for the acquisition	$	8,367,173

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

	Estimated Fair Value
Cash	$	425,316
Accounts receivable, net		1,632,354
Other receivables		1,279
Cost in excess of billings		592,747
Inventory		1,572,529
Prepaid expenses		3,794
Current deferred tax asset		18,692
Property and equipment, net of accumulated depreciation		56,005
Deposits		12,084
Deferred tax asset long term		277,126
Goodwill		8,547,540
Total assets acquired	$	13,139,466
Lines of credit payable		(1,794,301	)
Accounts payable		(1,637,815	)
Accrued expense		(886,227	)
Billings in excess of cost		(322,391	)
Notes payable		(131,559	)
Total net assets acquired	$	8,367,173

XML

Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) [Line Items]
Intangible Assets, Net (Excluding Goodwill)	$ 18,630		$ 24,687
Patents [Member] | Minimum [Member]
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Patents [Member] | Maximum [Member]
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years
Patents [Member]
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) [Line Items]
Intangible Assets, Net (Excluding Goodwill)	18,630		24,687
Amortization of Intangible Assets	$ 6,057	$ 3,519
Minimum [Member]
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Maximum [Member]
Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years

XML

Note 10 - Earnings Per Share (Details) (USD $)				9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Oct. 09, 2013	Sep. 30, 2014 Equity Option [Member]	Sep. 30, 2013 Equity Option [Member]	Sep. 30, 2014 Warrant [Member]	Sep. 30, 2013 Warrant [Member]	Sep. 30, 2014 Minimum [Member]	Sep. 30, 2013 Minimum [Member]	Sep. 30, 2014 Maximum [Member]	Sep. 30, 2013 Maximum [Member]
Note 10 - Earnings Per Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)				2,416,630	2,564,130	7,425,575	7,025,575
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 2.59	$ 2.65						$ 1.50	$ 1.50	$ 3.60	$ 3.60
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 2.70					$ 1.50	$ 1.50	$ 4.06	$ 4.06

XML

Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current Assets:
Cash	$ 6,736,113	$ 4,884,275
Accounts receivable, net	3,804,426	2,341,070
Other receivables	261,594	231,998
Cost in excess of billing	1,065,279	406,997
Inventories	5,397,011	4,258,606
Prepaid expenses	89,210	12,021
Current deferred tax asset	133,927	104,143
Total Current Assets	17,487,560	12,239,110
Property and Equipment, net accumulated depreciation	4,856,957	5,829,404
Other Assets:
Other investments	6,297	6,882
Long term deferred tax asset	3,022,692	1,863,349
Goodwill	7,980,327	0
Other intangible assets, net	18,630	24,687
Deposits	265,408	271,916
Total Other Assets	11,293,354	2,166,834
Total Assets	33,637,871	20,235,348
Current Liabilities:
Lines of credit	2,406
Current portion of capital lease obligations	181,595	208,419
Accounts payable	2,077,934	1,586,962
Accrued expenses	1,254,048	1,440,522
Billing in excess of cost	45,348	96,104
Accrued income taxes payable		2,000
Deferred revenue / customer deposits	75,801	1,212,434
Total Current Liabilities	3,637,132	4,546,441
Long-term capital lease obligations, less current portion	436,588	554,360
Total Long-Term Liabilities	436,588	554,360
Total Liabilities	4,073,720	5,100,801
Stockholder’s Equity:
Common stock; par value $0.001, 100,000,000 shares authorized, 39,304,782 and 27,212,500 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	39,305	27,213
Additional paid-in capital	35,568,888	18,700,574
Accumulated deficit	(3,486,851)	(2,316,784)
Deferred compensation	(526,568)	(1,008,450)
Other comprehensive income, net	(2,046,330)	(292,565)
Non-controlled interest in subsidiaries	15,707	24,559
Total Stockholders' Equity	29,564,151	15,134,547
Total Liabilities and Stockholder’s Equity	$ 33,637,871	$ 20,235,348

XML

Note 7 - Leases (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Note 7 - Leases (Details) [Line Items]
Operating Leases, Rent Expense	$ 539,443	$ 578,313
Capital Leased Assets, Gross	1,531,714		1,600,254
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation	975,838		907,728
Depreciation	1,258,479	1,216,745
Interest Expense, Lessee, Assets under Capital Lease	30,227	38,442
Assets Held under Capital Leases [Member]
Note 7 - Leases (Details) [Line Items]
Depreciation	153,378	160,993
Capital Lease Obligations [Member] | Capital Lease 1 [Member]
Note 7 - Leases (Details) [Line Items]
Debt Instrument, Periodic Payment	11,112
Capital Lease Obligations [Member] | Capital Lease 2 [Member]
Note 7 - Leases (Details) [Line Items]
Debt Instrument, Periodic Payment	4,306
Capital Lease Obligations [Member] | Capital Lease 3 [Member]
Note 7 - Leases (Details) [Line Items]
Debt Instrument, Periodic Payment	2,788
Capital Lease Obligations [Member] | Capital Lease 4 [Member]
Note 7 - Leases (Details) [Line Items]
Debt Instrument, Periodic Payment	2,152
Capital Lease Obligations [Member] | Capital Lease 5 [Member]
Note 7 - Leases (Details) [Line Items]
Debt Instrument, Periodic Payment	704
Capital Lease Obligations [Member] | Capital Lease 6 [Member]
Note 7 - Leases (Details) [Line Items]
Debt Instrument, Periodic Payment	$ 634

XML

(Unaudited) Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows from Operating Activities:
Net Loss	$ (1,176,097)	$ (2,896,066)
Adjustments to reconcile net loss to net cash provided by operations:
Depreciation and amortization	1,264,536	1,220,264
Share-base compensation	372,960	1,051,857
Bad debt expense	131,111	45,425
Obsolete inventory expense		143,135
Change in deferred tax asset / liability	(893,309)	(1,058,739)
(Gain) Loss on sale of equipment		2,135
Changes in assets and liabilities:
(Increase) decrease in accounts receivable	9,570	1,177,222
(Increase) decrease in inventory	434,124	(919,145)
(Increase) decrease in prepaid expenses/deposits	(54,803)	64,128
Increase (decrease) in accounts payable	(1,146,846)	(845,102)
Increase (decrease) in accrued expenses	(2,211,334)	76,888
Increase (decrease) long term contracts	(438,682)	(294,416)
Total Adjustments	(2,532,673)	663,652
Net Cash Provided (Used) by Operating Activities	(3,708,770)	(2,232,414)
Cash Flows from Investing Activities:
Purchase of property and equipment	(190,440)	(392,555)
Acquisition of Provital Solutions AS	(1,874,684)
Purchase of long-term investments		(23,090)
Net Cash Used by Investing Activities	(2,065,124)	(415,645)
Cash Flows from Financing Activities:
Payments on notes payable	(131,559)
Net payment on lines of credit	(1,791,895)
Net (payments) on capital lease obligation	(144,596)	(132,144)
Proceeds from issuance of common stock and warrants	12,071,250	450,000
Payment of stock offering costs	(1,149,096)
Net Cash Provided by Financing Activities	8,854,104	317,856
Loss on Currency Translation	(1,228,372)	19,517
Net Increase (Decrease) in Cash and Cash Equivalents	1,851,838	(2,310,686)
Cash and Cash Equivalents at Beginning of Period	4,884,275	3,873,338
Cash and Cash Equivalents at End of Period	6,736,113	1,562,652
Supplemental Disclosures of Cash Flow Information:
Interest	40,914	39,038
Income Taxes	1,000	1,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Value of stock issued to acquire Provital Solutions AS	6,067,173
Total	6,440,133	1,051,857
Employee Stock Option [Member]
Adjustments to reconcile net loss to net cash provided by operations:
Share-base compensation	(6,439)	328,613
Restricted Stock [Member]
Adjustments to reconcile net loss to net cash provided by operations:
Share-base compensation	319,999	284,444
Stock Granted for Services [Member]
Adjustments to reconcile net loss to net cash provided by operations:
Share-base compensation		320,000
Warrants Issued for Services [Member]
Adjustments to reconcile net loss to net cash provided by operations:
Share-base compensation	$ 59,400	$ 118,800

XML

Note 11 - Stockholders' Equity (Details) - Status of Options Granted and Changes During the Year (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013
Status of Options Granted and Changes During the Year [Abstract]
Shares	2,416,630	2,416,630	2,564,130
Weighted Average Exercise Price	$ 2.59	$ 2.59	$ 2.65
Average Remaining Life		292 days	1 year 233 days
Intrinsic Value	$ 13,200	$ 13,200	$ 283,125
Vested and expected to vest	2,416,630	2,416,630
Vested and expected to vest	$ 2.59	$ 2.59
Vested and expected to vest		292 days
Vested and expected to vest	13,200	13,200
Exercisable end of period	2,083,297	2,083,297
Exercisable end of period	$ 2.70	$ 2.70
Exercisable end of period		204 days
Exercisable end of period	$ 13,200	$ 13,200
Granted		500,000
Granted		$ 1.90
Granted		2 years 120 days
Exercised	(47,500)	(47,500)
Exercised	$ 1.50	$ 1.50
Forfeited		(600,000)
Forfeited		$ 2.35

XML

Note 2 - Inventory (Details) - Summary of Inventory (USD $)	Sep. 30, 2014	Dec. 31, 2013
Summary of Inventory [Abstract]
Furnace parts and supplies	$ 1,146,003	$ 1,025,225
Raw materials	1,683,858	631,524
Work in process	1,585,494	1,799,888
Finished goods and filtration systems	1,090,110	1,062,865
Reserve for obsolescence	(108,454)	(260,896)
Net Inventory	$ 5,397,011	$ 4,258,606

XML

Note 13 - Acquisition (Details) - Allocation of Consideration Transfered (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2014 Provital Solutions AS [Member]	Jul. 29, 2014 Provital Solutions AS [Member]
Note 13 - Acquisition (Details) - Allocation of Consideration Transfered [Line Items]
Cash					$ 425,316
Accounts receivable, net					1,632,354
Other receivables					1,279
Cost in excess of billings					592,747
Inventory					1,572,529
Prepaid expenses					3,794
Current deferred tax asset					18,692
Property and equipment, net of accumulated depreciation					56,005
Deposits					12,084
Deferred tax asset long term					277,126
Goodwill	7,980,327	0	0	7,980,327	8,547,540
Total assets acquired					13,139,466
Lines of credit payable					(1,794,301)
Accounts payable					(1,637,815)
Accrued expense					(886,227)
Billings in excess of cost					(322,391)
Notes payable					(131,559)
Total net assets acquired					$ 8,367,173

XML

Note 1 - Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Allowance for Credit Losses on Financing Receivables [Table Text Block]

	2014			2013
Allowance for doubtful accounts at the beginning of the period	$	608,356		$	1,243,500
Bad debt expense		131,111			72,548
Acquired in purchase of Provital Solutions AS		253,584			-
Amount of receivables written off		-			(770,738	)
Effect of currency translation		(80,846	)		63,046
Allowance for doubtful accounts at the end of the period	$	912,205		$	608,356

XML

Note 3 - Property and Equipment (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Property, Plant and Equipment [Abstract]
Depreciation	$ 1,258,479	$ 1,216,745

XML

Note 3 - Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2014

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

	Useful Life		2014			2013
Production equipment		3 - 10	$	11,045,097		$	11,542,740
Lab equipment		3 - 10		166,019			181,432
Computer equipment		3 - 5		300,837			276,013
Vehicles		3		99,151			38,221
Furniture and fixture		5		136,101			68,169
Leasehold improvements		10		1,049,766			1,059,605
				12,796,971			13,166,180
Less Accumulated Depreciation				(7,940,014	)		(7,336,776	)
Net Property and Equipment			$	4,856,957		$	5,829,404

XML

Note 1 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business and Basis of Presentation

The consolidated financial statements include the accounts of LiqTech International, Inc. (“Parent”) and its subsidiaries. The terms "Company", “us", "we" and "our" as used in this report refer to Parent and its subsidiaries, which are set forth below. The Company engages in the development, design, production, marketing and sale of atuomated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America. Set forth below is a description of Parent and each of its subsidiaries:

LiqTech International, Inc., a Nevada corporation organized in July 2004, formerly known as Blue Moose Media, Inc.

LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in May 2011.

LiqTech International AS, a Danish corporation, incorporated on January 15, 2000 (“LiqTech Int. DK”), a 100% owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.

LiqTech NA, Inc. (“LiqTech NA”), incorporated in Delaware on July 1, 2005, a 100% owned subsidiary of LiqTech USA as of December 31, 2013, prior to December 31, 2013 LiqTech NA, Inc. was owned 90% by LiqTech International AS and 10% by LiqTech USA, LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.

LiqTech Asia (“LiqTech Asia”) a 60% owned subsidiary of LiqTech Int. DK, incorporated in South Korea on July 20, 2006, is currently a dormant subsidiary.

LiqTech Germany (“LiqTech Germany”) a 100% owned subsidiary of LiqTech Int. DK, incorporated in Germany on December 9, 2011, engages in marketing and sale of liquid filters in Germany.

LiqTech PTE Ltd, (“LiqTech Sing”) a 95% owned subsidiary of LiqTech Int. DK, incorporated in Singapore on January 19, 2012, engages in marketing and sale of liquid filters in Singapore and other countries in the area.

Provital Solutions AS, a Danish Corporation ("Provital") was incorporated on September 1, 2009 and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of Provital from the date of acquisition on July 31st, 2014.

The accompanying financial statements are unaudited. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2014 and 2013 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2013 audited financial statements. The results of operations for the periods ended September 30, 2014 and 2013 are not necessarily indicative of the operating results for the full year.

Consolidation--The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.

Functional Currency / Foreign currency translation -- The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The Functional Currency of LiqTech Int. DK and Provital Solutions AS is the Danish Krone (“DKK”), the functional currency of LiqTech Germany is the Euro and the functional currency of LiqTech Singapore is the Singapore Dollar, the functional Currency of LiqTech Asia is South Korean Won. The Company’s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the periods ended September 30, 2014 and 2013. Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.

Cash and Cash Equivalents-- The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company had no balances held in financial institution in the United States in excess of federally insured amounts at September 30, 2014 and December 31, 2013.

Accounts Receivable-- Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence.

The roll forward of the allowance for doubtful accounts for the nine months ended September 30, 2014 and the year ended December 31, 2013 is as follows:

	2014			2013
Allowance for doubtful accounts at the beginning of the period	$	608,356		$	1,243,500
Bad debt expense		131,111			72,548
Acquired in purchase of Provital Solutions AS		253,584			-
Amount of receivables written off		-			(770,738	)
Effect of currency translation		(80,846	)		63,046
Allowance for doubtful accounts at the end of the period	$	912,205		$	608,356

Inventory-- Inventory is carried at the lower of cost or market, as determined on the first-in, first-out method.

Property and Equipment-- Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets which range from three to ten years (See Note 3).

Long-Term Investments-- Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information may be more limited, may not be as timely as and may be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.

Intangible Assets-- Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC”) Topic 350, “Goodwill and Other Intangible Assets” and amortized the patents on a straight line basis over the estimated useful life of two to ten years.  

Goodwill - Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.

Revenue Recognition and Sales Incentives-- The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (SAB 101), FASB ASC 605 Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collection of the resulting receivable is reasonable assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.

The Company has received various long-term contracts for the manufacturing and installation of water filtration and treatment systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long term or grant multiplied by the contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.

Project costs of the long term contracts and grants include all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.

In Denmark, Value Added Tax (“VAT”) of 25% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.

Advertising Cost-- Cost incurred in connection with advertising of the Company’s products is expensed as incurred. Such costs amounted to $17,120 and $30,556, for the nine months ended September 30, 2014 and 2013, respectively.

Research and Development Cost-- The Company expenses research and development costs for the development of new products and systems as incurred. Included in operating expense for the nine months ended September 30, 2014 and 2013 were $223,532, and $350,515, respectively, of research and development costs.

Income Taxes-- The Company accounts for income taxes in accordance with FASB ASC Topic 740 Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.

Income (Loss) Per Share-- The Company calculates earnings (loss) per share in accordance with FASB ASC 260 Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options that have been granted but have not been exercised.

Stock Options-- The Company has granted stock options to certain employees. See Note 13. During the years presented in the accompanying consolidated financial statements, the Company has granted options. The Company accounts for options in accordance with the provisions of FASB ASC Topic 718, Compensation – Stock Compensation. Non-cash compensation costs of $372,960 and $1,051,857 have been recognized for the estimated vesting of options granted to employees with an associated recognized tax benefit of $0 for the nine months ended September 30, 2014 and 2013, respectively.

Fair Value of Financial Instruments-- The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic 820. The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

● Level 1. Observable inputs such as quoted prices in active markets for identical assets or liabilities;

● Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

● Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.

Accounting Estimates-- The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.

Recent Accounting Pronouncements-- In May 2014, the Financial Accounting Standards Board issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard is effective beginning in the first quarter of 2017; early adoption is prohibited. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method nor have we determined the impact of the new standard on our consolidated condensed financial statements. 

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Common Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	39,304,782	27,212,500
Common Stock, shares outstanding	39,304,782	27,212,500

XML

Note 11 - Stockholders' Equity

9 Months Ended

Sep. 30, 2014

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

NOTE 11 - STOCKHOLDERS' EQUITY

Common Stock  --  Parent has 100,000,000 authorized shares of common stock, $0.001 par value. As of September 30, 2014 and December 31, 2013, respectively, there were 39,304,782 and 27,212,500 common shares issued and outstanding.   

Voting-- Holders of Parent common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors, and do not have any right to cumulate votes in the election of directors. 

Dividends-- Subject to the rights and preferences of the holders of any series of preferred stock which may at the time be outstanding, holders of Parent common stock are entitled to receive ratably such dividends as our Board of Directors from time to time may declare out of funds legally available. 

Liquidation Rights-- In the event of any liquidation, dissolution or winding-up of affairs of Parent, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock, the holders of Parent common stock will be entitled to share ratably in the distribution of any of our remaining assets.  

Other Matters-- Holders of Parent common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions with respect to the common stock. All of the issued and outstanding shares of common stock on the date of this report are validly issued, fully paid and non-assessable.

Preferred Stock-- Our Board of Directors has the authority to issue Parent preferred stock in one or more classes or series and to fix the designations, powers, preferences and rights, the qualifications, limitations or restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without further vote or action by the stockholders. The issuance of Parent preferred stock may have the effect of delaying, deferring or preventing a change in control of us without further action by the stockholders and may adversely affect the voting and other rights of the holders of common stock.

Common Stock Issuance

On July 28, 2014, Parent completed a registered public offering of its common stock. As part of the closing, Parent issued 8,000,000 shares of common stock at a per share price of $1.50 and generated net proceeds of approximately $10.8 million, net of offering costs of $1,149,096. 

On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Provital Shares”) of Provital Solutions A/S, a Danish company (“Provital”) and as part of the consideration for the Provital Shares, the Company issued 4,044,782 common shares. 

During the third quarter 2014, the Company issued 47,500 shares of common stock in connection with the exercise of 47,500 stock options with an exercise price of $1.50 each.

During the year 2013, the Company issued 100,000 shares of common stock valued at $320,000 for services rendered.

The Company issued an additional 300,000 shares of restricted stock valued at $960,000 for services provided and to be provided by the board of directors. The Company will recognized the non-cash compensation of the award over the requisite service period, of which 133,333 shares vested on December 31, 2013, 133,333 shares will vest on December 31, 2014 and 33,334 shares will vest on December 31, 2015. As of September 30, 2014, the Company has recorded deferred compensation of $320,001 and non-cash compensation expense of $320,000 relating to the awards for the nine months ended September 30, 2014.

On October 9, 2013 we announced that the warrant and option exercise raised $4,051,000 with holders exercising 2,701,000 warrants and stock options which included the exercise of 100,000 warrants by Aldo Petersen, Chairman of LiqTech, 25,000 stock options by Lasse Andreassen, founder and former board member of LiqTech and 50,000 stock options by Soren Degn, CFO of LiqTech. The board noted that the additional capital was an orderly solution to improving the Company's capital structure as well as enhancing the ability of LiqTech to list on an exchange. In addition, the new capital gave the Company additional flexibility to generate new orders and to sustain future growth.

Common Stock Purchase Warrants

A summary of the status of the Warrants outstanding at September 30, 2014 is presented below:

		Warrants Outstanding						Warrants Exercisable
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50		3,874,000		2.25	$	1.50		3,874,000	$	1.50
$	1.65		400,000		4.83	$	1.65		400,000	$	1.65
$	2.35		400,000		0.50	$	2.35		400,000	$	2.35
$	2.70		2,626,000		2.25	$	2.70		2,626,000	$	2.70
$	4.0625		125,575		2.43	$	4.0625		125,575	$	4.06
Total			7,425,575		2.30	$	2.02		7,425,575	$	2.02

At September 30, 2014, the Company had no non-vested warrants. We have recorded non-cash compensation expense of $59,400 for the period ended September 30, 2014 related to the warrants issued.

The exercise price of the warrants and the number of shares underlying the warrants are subject to adjustment for stock dividends, subdivisions of the outstanding shares of common stock and combinations of the outstanding shares of common stock. For so long as the warrants remain outstanding, we are required to keep reserved from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of the shares underlying the warrants.

On July 28, 2014, the Company issued to the Underwriter in our public offering, for a price of $50, a warrant to purchase 400,000 shares at an exercise price of $1.65 per share. The warrants are immediately exercisable and will remain exercisable for five years.

On October 9, 2013, the Company issued 2,626,000 new warrants equal to the number of warrants exercised by the warrant holder having the same terms and conditions as the warrants exercised by the warrant holder, respectively, except each warrant issued has a strike price of $2.70 per share, the closing bid price of Parent’s common stock as quoted on the OTCBB on September 23, 2013.  The net proceeds from the offering were allocated to the stock and warrants based on their relative fair values. The Company recorded the relative fair value of the warrants of $1,124,928 as stock offering costs.

Stock Options

In August 2011, Parent’s Board of Directors adopted a Stock Option Plan (the “Plan”). Under the terms and conditions of the Plan, the board is empowered to grant stock options to employees, officers, and directors of the Companies. At September 30, 2014, 2,416,630 options were granted and outstanding under the Plan. 

The Company recognizes compensation costs for stock option awards to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average assumptions used to estimate the fair values of the stock options granted using the Black-Scholes option-pricing model are as follows:

	LiqTech International, Inc.
Expected term (in years)		3-4
Volatility		40.74
Risk free interest rate		0.67	%
Dividend yield		0	%

The Company recognized stock based compensation expense (forfeitures) related to the options of $(6,439) and $613,057 for the nine months ended September 30, 2014 and 2013, respectively. At September 30, 2014 the Company had approximately $313,233 of unrecognized compensation cost related to non-vested options expected to be recognized through January 27, 2017.

A summary of the status of the options outstanding under the Company’s stock option plans at September 30, 2014 is presented below: 

		Options Outstanding						Options Exercisable
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50		330,000		0.40	$	1.50		330,000	$	1.50
$	1.90		500,000		2.33	$	1.90		166,667	$	1.90
$	2.70		75,000		0.40	$	2.70		75,000	$	2.70
$	3.00 - 3.60		1,511,630		0.41	$	3.06		1,511,630	$	3.06
Total			2,416,630		0.80	$	2.59		2,083,297	$	2.70

A summary of the status of the options at September 30, 2014, and changes during the period is presented below:

	September 30, 2014
	Shares			Weighted Average Exercise Price		Average Remaining Life		Weighted Average Intrinsic Value
Outstanding at beginning of period		2,564,130		$	2.65		1.64	$	283,125
Granted		500,000			1.90		2.33		-
Exercised		(47,500	)		1.50		-		-
Forfeited		(600,000	)		2.35		-		-
Expired		-			-		-		-
Outstanding at end of period		2,416,630		$	2.59		0.80	$	13,200
Vested and expected to vest		2,416,630		$	2.59		0.80	$	13,200
Exercisable end of period		2,083,297		$	2.70		0.56	$	13,200

At September 30, 2014, the Company had 333,333 non-vested options with a weighted average exercise price of $1.90 and with a weighted average grant date fair value of $0.805, resulting in unrecognized compensation expense of $313,233, which is expected to be expensed over a weighted-average period of 2.33 years.

The total intrinsic value of options at September 30, 2014 was $13,200. Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at September 30, 2014 (for outstanding options), less the applicable exercise price. 

XML

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 12, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	LIQTECH INTERNATIONAL INC
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		39,304,782
Amendment Flag	false
Entity Central Index Key	0001307579
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

XML

Note 12 - Significant Customers / Concentration

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

NOTE 12 - SIGNIFICANT CUSTOMERS / CONCENTRATION

The Company had no customers that accounted for more than 10% of total sales at September 30, 2014 and 2013.

The Company sells products throughout the world; sales by geographical region are as follows for the three and nine months ended September 30, 2014 and 2013: 

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2014		2013		2014		2013
United States and Canada	$	1,066,463	$	736,958	$	2,841,932	$	2,264,368
Australia		179,981		55,093		264,296		223,483
South America		-		4,679		16,845		30,058
Asia		696,102		493,542		1,191,035		1,645,025
Europe		2,988,860		1,659,333		7,788,487		4,991,740
	$	4,931,406	$	2,949,605	$	12,102,595	$	9,154,674

The Company’s sales by product line are as follows for the three and nine months ended September 30, 2014 and 2013:

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2014		2013		2014		2013
Ceramic diesel particulate	$	1,519,204	$	1,386,565	$	5,137,720	$	4,858,841
Liquid filters and systems		3,256,689		1,440,849		6,639,362		3,679,719
Kiln furniture		155,513		122,191		325,513		616,114
	$	4,931,406	$	2,949,605	$	12,102,595	$	9,154,674

XML

(Unaudited) Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net Sales	$ 4,931,406	$ 2,949,605	$ 12,102,595	$ 9,154,674
Cost of Goods Sold	3,464,284	2,675,132	9,229,131	8,025,657
Gross Profit	1,467,122	274,473	2,873,464	1,129,017
Operating Expenses:
Selling expenses	831,990	654,005	2,430,814	1,943,522
General and administrative expenses	738,761	568,944	2,174,942	1,773,073
Non-cash compensation expenses	(19,663)	276,969	372,960	1,051,857
Research and development expenses	83,113	92,276	223,532	350,515
Total Operating Expense	1,634,201	1,592,194	5,202,248	5,118,967
Loss from Operations	(167,079)	(1,317,721)	(2,328,784)	(3,989,950)
Other Income (Expense)
Interest and other income	16,032	9,313	29,777	11,713
Interest (expense)	(18,794)	(14,381)	(40,914)	(39,038)
Gain (loss) on investments	9		(832)
Gain (loss) on currency transactions	237,551	115,011	192,226	78,037
Loss on sale of fixed assets				(2,135)
Total Other Income (Expense)	234,798	109,943	180,257	48,577
Income (Loss) Before Income Taxes	67,719	(1,207,778)	(2,148,527)	(3,941,373)
Income Tax Expense (Benefit)	(276,870)	(303,784)	(972,430)	(1,045,307)
Net Income (Loss)	344,589	(903,994)	(1,176,097)	(2,896,066)
Less Net Income (Loss) Attributable To Non-Controlled Interests in Subsidiaries	(2,915)	(38)	(6,029)	(14,197)
Net Income (Loss) Attributable To LiqTech	$ 347,504	$ (903,956)	$ (1,170,068)	$ (2,881,869)
Basic Earnings (Loss) Per Share (in Dollars per share)	$ 0.01	$ (0.04)	$ (0.04)	$ (0.12)
Weighted Average Common Shares Outstanding (in Shares)	35,613,164	24,511,500	30,043,493	24,329,082
Diluted Earnings (Loss) Per Share (in Dollars per share)	$ 0.01	$ (0.04)	$ (0.04)	$ (0.012)
Weighted Average Common Shares Outstanding Assuming Dilution (in Shares)	36,034,570	24,511,500	30,043,493	24,329,082

XML

Note 6 - Lines of Credit

9 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

NOTE 6 — LINES OF CREDIT

Provital Solutions AS has a DKK 2,000,000 (approximately $340,000 at September 30, 2014) standby line of credit with a bank, subject to certain borrowing base limitations. Outstanding borrowings are due on demand. Interest is calculated based on a variable interest rate and is payable quarterly. As of September 30, 2014, the interest on this line of credit was at 3.50%. This line of credit is guaranteed by Vækstfonden (the Danish state's investments fund) and is also secured by certain of Provital Solutions AS’ assets like receivables, inventory, equipment etc. There was $2,406 outstanding as of September 30, 2014. At September 30, 2014, there was approximately $335,000 available under this credit line. In general, lines of credit in Denmark are due on demand. We do not believe that any of our lines of credit will be called, but if they were called, we believe that we could refinance with other lenders in Denmark with similar terms.

In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a credit line of DKK 5,000,000 (approximately $845,000 at September 30, 2014) with a bank, subject to certain base limitations. As of September 30, 2014, we had DKK 1,379,646 (approximately $230,000)  in working guarantee against the line.

XML

Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets

9 Months Ended

Sep. 30, 2014

Disclosure Text Block [Abstract]

Intangible Assets Disclosure [Text Block]

NOTE 5 - DEFINITE-LIFE INTANGIBLE ASSETS / GOODWILL AND INDEFINITE-LIFE INTANGIBLE ASSETS

Definite-Life Intangible assets - At September 30, 2014 and December 31, 2013, definite-life intangible assets, net of accumulated amortization, consisted of patents on the Company’s products of $18,630 and $24,687, respectively. The patents are recorded at cost and amortized over two to ten years. Amortization expense for the nine months ended September 30, 2014 and 2013 was $6,057 and $3,519, respectively.

Expected future amortization expense for the years ended are as follows: 

Year ending December 31,	Amortization Expenses
2014	$	1,325
2015		5,299
2016		5,299
2017		3,218
2018		2,707
Thereafter		782
Total Amortization Expenses	$	18,630

Goodwill - The following is a summary of goodwill:

	For the periods ended
	September 30, 2014			December 31, 2013
Goodwill at beginning of period	$	-		$	-
Goodwill resulting from the Provital acquisition		8,547,540			-
Effect of currency translation		(567,213	)		-
Goodwill at end of period	$	7,980,327		$	-

Goodwill consists of:

	For the periods ended
	September 30, 2014		December 31, 2013
Provital Solutions AS	$	7,980,327	$	-
Total Goodwill	$	7,980,327	$	-

XML

Note 2 - Inventory (Tables)

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

	2014			2013
Furnace parts and supplies	$	1,146,003		$	1,025,225
Raw materials		1,683,858			631,524
Work in process		1,585,494			1,799,888
Finished goods and filtration systems		1,090,110			1,062,865
Reserve for obsolescence		(108,454	)		(260,896	)
Net Inventory	$	5,397,011		$	4,258,606

XML

Note 13 - Acquisition

9 Months Ended

Sep. 30, 2014

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

NOTE 13 – ACQUISITION

Acquisition -On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Provital Shares”) of Provital Solutions A/S, a Danish company (“Provital”) from Masu A/S, a Danish company (“MASU”). In consideration for the Provital Shares, MASU received cash consideration in the sum of DKK 12,600,000, that is, approximately USD $2,300,000, and 4,044,782 shares of the Company’s common stock (the “Payment Shares”). One-third (1/3) of the Payment Shares shall be subject to a lock-up period of six (6) months. The remaining two-thirds (2/3) of the Payment Shares shall be held in escrow and one-third of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2014, achieving (i) gross revenues of not less than DKK 65,000,000, that is, approximately USD $10,988,639 and EBITDA of DKK 6,500,000, that is, approximately USD $1,098,864 or (ii) EBITDA of not less than DKK 10,000,000, that is, approximately USD $1,690,560 and gross revenues of not less than DKK 50,000,000, that is, approximately USD $8,452,800. Another one-third (1/3) of the Payment Shares will be released from escrow contingent upon Provital, for the year ending December 31, 2015, achieving (i) gross revenues of not less than DKK 120,000,000, that is, approximately USD $20,286,719 and EBITDA of DKK 12,000,000, that is, approximately USD $2,028,672 or (ii) EBITDA of not less than DKK 16,000,000, that is, approximately USD $2,704,896 and gross revenues of not less than DKK 80,000,000, that is, approximately USD $13,524,479.   

The purchase agreement includes “catch up” provisions that provide that the Payment Shares placed in escrow will be released from escrow if Provital (1) for the years ending December 31, 2014 and December 31, 2015, achieves accumulated gross revenues (i) exceeding DKK 185,000,000, that is, approximately USD $31,275,358 and EBITDA of DKK 18,500,000, that is, approximately USD $3,127,536 or (ii) EBITDA of not less than DKK 26,000,000, that is, approximately USD $4,395,456 and gross revenues of not less than DKK 130,000,000, that is, approximately USD $21,977,279 or (2) for the year ending December 31, 2016, achieves gross revenues exceeding DKK 105,000,000, that is, approximately USD $17,750,879 and EBITDA of not less than DKK 21,000,000, that is, approximately USD $3,550,176.

Current fair value of the consideration transferred to acquire Provital Solutions AS:

Cash	$	2,300,000
4,044,782 common shares at $1.50 a share		6,067,173
Current consideration transferred for the acquisition	$	8,367,173

Total consideration transferred was allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values at the acquisition date as set forth below. The Company believes that the acquisition of Provital Solutions AS facilitates the Company’s entry into the water filtration systems industry, diversifies its product revenue and enhances its strength in providing whole system offerings. These factors contributed to consideration transferred in excess of the fair value of Provital Solutions’ net tangible and intangible assets acquired, resulting in the Company recording goodwill in connection with the transaction. Management estimated the fair values of tangible and intangible asset and liabilities in accordance with the applicable accounting guidance for business combinations.

The Company’s allocation of consideration transferred for Provital Solutions AS is as follows:

	Estimated Fair Value
Cash	$	425,316
Accounts receivable, net		1,632,354
Other receivables		1,279
Cost in excess of billings		592,747
Inventory		1,572,529
Prepaid expenses		3,794
Current deferred tax asset		18,692
Property and equipment, net of accumulated depreciation		56,005
Deposits		12,084
Deferred tax asset long term		277,126
Goodwill		8,547,540
Total assets acquired	$	13,139,466
Lines of credit payable		(1,794,301	)
Accounts payable		(1,637,815	)
Accrued expense		(886,227	)
Billings in excess of cost		(322,391	)
Notes payable		(131,559	)
Total net assets acquired	$	8,367,173

Goodwill

The $8,547,540 of goodwill represents the excess of consideration transferred over the fair value of assets acquired and liabilities assumed and is attributable to the benefits expected from combining the Company’s operations with Provital Solutions AS. This goodwill is not deductible for income tax purposes.

XML

Note 9 - Income Taxes

9 Months Ended

Sep. 30, 2014

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

 NOTE 9 – INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC Topic 740, Accounting for Income Taxes; which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carry forwards. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company’s future earnings, and other future events, the effects of which cannot be determined.

The temporary differences, tax credits and carry forwards gave rise to the following deferred tax asset (liabilities) at September 30, 2014 and December 31, 2013:  

	2014			2013
Vacation accrual	$	4,161		$	4,161
Allowance for doubtful Accounts		31,566			13,955
Long term contracts		13,036			-
Reserve for obsolete inventory		85,164			86,027
Net current tax assets	$	133,927		$	104,143
Business tax credit carryover		20,184			20,184
Deferred compensation		202,309			202,309
Net operating loss carryover		3,525,333			2,367,568
Excess of book over tax depreciation		(725,134	)		(726,712	)
Long term deferred tax asset	$	3,022,692		$	1,863,349

In accordance with prevailing accounting guidance, the Company is required to recognize and disclose any income tax uncertainties. The guidance provides a two-step approach to recognizing and measuring tax benefits and liabilities when realization of the tax position is uncertain. The first step is to determine whether the tax position meets the more-likely-than-not condition for recognition and the second step is to determine the amount to be recognized based on the cumulative probability that exceeds 50%.

The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company’s future earnings, and other future events, the effects of which can difficult to determine and can only be estimated. Management estimates that it is more likely than not that the Company will generate adequate net profits to use the deferred tax assets; management has estimated that all of the deferred tax will be realized and consequently, a valuation allowance was not recorded.

A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company’s effective rate is as follows for the nine months ended September 30, 2014 and 2013: 

	2014			2013
Computed tax at expected statutory rate	$	(1,107,897	)	$	(1,335,240	)
State and local income taxes, net of federal benefits		(24,703	)		(15,743	)
Non-deductible expenses		52,174			205,498
Non-US income taxed at different rates		107,996			100,735
Other items		-			(557	)
Income tax (benefit)	$	(972,430	)	$	(1,045,307	)

The components of income tax expense (benefit) from continuing operations for the nine months ended September 30, 2014 and 2013 consisted of the following:

	2014			2013
Current income tax expense:
Danish	$	-		$	-
Korean		1,020			-
Federal		-			-
State		-			-
Current tax expense	$	1,020		$	-
Net operating loss carryover		(973,450	)		(1,032,389	)
Allowance for doubtful accounts		-			-
Reserve for obsolete inventory		-			(12,918	)
Deferred tax expense	$	(973,450	)	$	(1,045,307	)
Income tax benefit	$	(972,430	)	$	(1,045,307	)

Deferred income tax expense / (benefit) results primarily from the reversal of temporary timing differences between tax and financial statement income. 

The Company files Danish and U.S. federal and Minnesota state income tax returns. LiqTech International AS is generally no longer subject to tax examinations for years prior to 2011 for their Danish tax returns. LiqTech NA is generally no longer subject to tax examinations for years prior to 2009 for U.S. federal and U.S. states tax returns.

XML

Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region [Line Items]
Net sales	$ 4,931,406	$ 2,949,605	$ 12,102,595	$ 9,154,674
Reportable Geographical Components [Member] | US and Canada [Member]
Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region [Line Items]
Net sales	1,066,463	736,958	2,841,932	2,264,368
Reportable Geographical Components [Member] | AUSTRALIA
Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region [Line Items]
Net sales	179,981	55,093	264,296	223,483
Reportable Geographical Components [Member] | South America [Member]
Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region [Line Items]
Net sales		4,679	16,845	30,058
Reportable Geographical Components [Member] | Asia [Member]
Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region [Line Items]
Net sales	696,102	493,542	1,191,035	1,645,025
Reportable Geographical Components [Member] | Europe [Member]
Note 12 - Significant Customers / Concentration (Details) - Net Sales by Geographical Region [Line Items]
Net sales	$ 2,988,860	$ 1,659,333	$ 7,788,487	$ 4,991,740

XML

Note 7 - Leases

9 Months Ended

Sep. 30, 2014

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]

NOTE 7 – LEASES

Operating Leases-- The Company leases office and production facilities under operating lease agreements expiring in August 2018, March 2017, February 2017, June 2017, December 2016 and June 2016. In some of these lease agreements, the Company has the right to extend.

The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of one year as of September 30, 2014 are as follows:

Year ending December	Operating Lease Payments
2014	$	169,334
2015		695,240
2016		693,791
2017		482,503
2018		287,962
Thereafter		-
Total Minimum Lease Payments	$	2,328,830

Lease expense charged to operations was $539,443 and $578,313 for the nine months ended September 30, 2014 and 2013, respectively.

Capital Leases -- The Company leases equipment on various variable rate capital leases currently calling for monthly payments of approximately $11,112, $4,306, $2,788, $2,152, $704 and $634 expiring through February 2018. Included in property and equipment, at September 30, 2014 and December 31, 2013, the Company had recorded equipment on capital lease at $1,531,714 and $1,600,254, respectively, with related accumulated depreciation of $975,838 and $907,728, respectively. 

During the nine months ended September 30, 2014 and 2013, depreciation expense for equipment on capital lease amounted to $153,378, and $160,993, respectively, and has been included in depreciation expense. During the nine months ended September 30, 2014 and 2013, interest expense on a capital lease obligation amounted to $30,227 and $38,442, respectively.

Future minimum capital lease payments are as follows for the periods ended December 31: 

	Capital Lease Payments
2014	$	70,077
2015		223,548
2016		216,916
2017		145,029
2018		28,282
Thereafter		-
Total minimum lease payments		683,852
Less amount representing interest		(65,669	)
Present value of minimum lease payments		618,183
Less current portion		(181,595	)
Long-term lease payments	$	436,588

XML

Note 8 - Agreements and Commitments

9 Months Ended

Sep. 30, 2014

Disclosure Text Block Supplement [Abstract]

Commitments Disclosure [Text Block]

NOTE 8 – AGREEMENTS AND COMMITMENTS

401(K) Profit Sharing Plan-- LiqTech NA has a 401(k) profit sharing plan and trust covering certain eligible employees. The amount LiqTech NA contributes is discretionary. For the nine months ended September 30, 2014 and 2013, matching contributions were expensed and totaled $12,110 and $11,902, respectively.

In connection with some orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a credit line of DKK 5,000,000 (approximately $845,000 at September 30, 2014) with a bank, subject to certain base limitations. As of September 30, 2014, we had DKK 1,379,646 (approximately $230,000) in working guarantee against the line.

XML

Note 10 - Earnings Per Share

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

NOTE 10 – EARNINGS PER SHARE

The following data shows the amounts used in computing earnings per share and the effect on income and the weighted average number of shares of potential dilutive common stock for the nine months ended September 30, 2014 and 2013:

	For the Three Months Ended September 30					For the Nine Months Ended September 30
	2014		2013			2014			2013
Income (Loss) attributable to LiqTech International Inc.	$	347,504	$	(903,956	)	$	(1,170,068	)	$	(2,881,869	)
Weighted average number of common shares used in basic earnings per share		35,613,164		24,511,500			30,043,493			24,329,082
Effect of dilutive securities, stock options and warrants		-		-			-			-
Weighted average number of common shares and potentially dilutive securities	$	36,034,570	$	24,511,500		$	30,043,493		$	24,329,082

For the nine months ended September 30, 2014, Parent had 2,416,630 options outstanding to purchase common stock of the Parent at $1.50 to $3.60 per share and Parent had 7,425,575 warrants outstanding to purchase common stock of the Parent at $1.50 to $4.06 per share, which were not included in the loss per share computation because their effect would be anti-dilutive.

For the nine months ended September 30, 2013, Parent had 2,564,130 options outstanding to purchase common stock of the Parent at $1.50 to $3.60 per share and Parent had 7,025,575 warrants outstanding to purchase common stock of the Parent at $1.50 to $4.06 per share, which were not included in the loss per share computation because their effect would be anti-dilutive.

XML

Note 13 - Acquisition (Details) - Current Fair Value of Consideration Transfered (Parentheticals) (Provital Solutions AS [Member], USD $)	1 Months Ended	37 Months Ended
	Jul. 29, 2014	Jul. 29, 2017
Provital Solutions AS [Member]
Business Acquisition, Contingent Consideration [Line Items]
Common shares, cost per share		$ 1.50
Common shares	4,044,782	4,044,782

XML

Note 13 - Acquisition (Details) - Current Fair Value of Consideration Transfered (Provital Solutions AS [Member])	1 Months Ended		37 Months Ended
	Jul. 29, 2014 USD ($)	Jul. 29, 2014 DKK	Jul. 29, 2017 USD ($)
Business Acquisition, Contingent Consideration [Line Items]
Cash	$ 2,300,000	12,600,000	$ 2,300,000
4,044,782 common shares at $1.50 a share			6,067,173
Current consideration transferred for the acquisition			$ 8,367,173

XML

Note 1 - Summary of Significant Accounting Policies (Details) - Allowance for Doubtful Accounts, Roll Forward (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Allowance for Doubtful Accounts, Roll Forward [Abstract]
Allowance for doubtful accounts at the beginning of the period	$ 608,356	$ 1,243,500	$ 1,243,500
Bad debt expense	131,111	45,425	72,548
Acquired in purchase of Provital Solutions AS	253,584
Amount of receivables written off			(770,738)
Effect of currency translation	(80,846)		63,046
Allowance for doubtful accounts at the end of the period	$ 912,205		$ 608,356

XML

Note 9 - Income Taxes (Details) - Reconciliation of Income Tax Expense (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Reconciliation of Income Tax Expense [Abstract]
Computed tax at expected statutory rate			$ (1,107,897)	$ (1,335,240)
State and local income taxes, net of federal benefits			(24,703)	(15,743)
Non-deductible expenses			52,174	205,498
Non-US income taxed at different rates			107,996	100,735
Other items				(557)
Income tax (benefit)	$ (276,870)	$ (303,784)	$ (972,430)	$ (1,045,307)

XML

Accounting Policies, by Policy (Policies)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Business and Basis of Presentation

The consolidated financial statements include the accounts of LiqTech International, Inc. (“Parent”) and its subsidiaries. The terms "Company", “us", "we" and "our" as used in this report refer to Parent and its subsidiaries, which are set forth below. The Company engages in the development, design, production, marketing and sale of atuomated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America. Set forth below is a description of Parent and each of its subsidiaries:

LiqTech International, Inc., a Nevada corporation organized in July 2004, formerly known as Blue Moose Media, Inc.

LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in May 2011.

LiqTech International AS, a Danish corporation, incorporated on January 15, 2000 (“LiqTech Int. DK”), a 100% owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.

LiqTech NA, Inc. (“LiqTech NA”), incorporated in Delaware on July 1, 2005, a 100% owned subsidiary of LiqTech USA as of December 31, 2013, prior to December 31, 2013 LiqTech NA, Inc. was owned 90% by LiqTech International AS and 10% by LiqTech USA, LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.

LiqTech Asia (“LiqTech Asia”) a 60% owned subsidiary of LiqTech Int. DK, incorporated in South Korea on July 20, 2006, is currently a dormant subsidiary.

LiqTech Germany (“LiqTech Germany”) a 100% owned subsidiary of LiqTech Int. DK, incorporated in Germany on December 9, 2011, engages in marketing and sale of liquid filters in Germany.

LiqTech PTE Ltd, (“LiqTech Sing”) a 95% owned subsidiary of LiqTech Int. DK, incorporated in Singapore on January 19, 2012, engages in marketing and sale of liquid filters in Singapore and other countries in the area.

Provital Solutions AS, a Danish Corporation ("Provital") was incorporated on September 1, 2009 and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of Provital from the date of acquisition on July 31st, 2014.

The accompanying financial statements are unaudited. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2014 and 2013 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2013 audited financial statements. The results of operations for the periods ended September 30, 2014 and 2013 are not necessarily indicative of the operating results for the full year.

Consolidation, Policy [Policy Text Block]

Consolidation--The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Functional Currency / Foreign currency translation -- The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The Functional Currency of LiqTech Int. DK and Provital Solutions AS is the Danish Krone (“DKK”), the functional currency of LiqTech Germany is the Euro and the functional currency of LiqTech Singapore is the Singapore Dollar, the functional Currency of LiqTech Asia is South Korean Won. The Company’s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the periods ended September 30, 2014 and 2013. Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents-- The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company had no balances held in financial institution in the United States in excess of federally insured amounts at September 30, 2014 and December 31, 2013.

Loans and Leases Receivable, Allowance for Loan Losses Policy [Policy Text Block]

Accounts Receivable-- Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence.

The roll forward of the allowance for doubtful accounts for the nine months ended September 30, 2014 and the year ended December 31, 2013 is as follows:

	2014			2013
Allowance for doubtful accounts at the beginning of the period	$	608,356		$	1,243,500
Bad debt expense		131,111			72,548
Acquired in purchase of Provital Solutions AS		253,584			-
Amount of receivables written off		-			(770,738	)
Effect of currency translation		(80,846	)		63,046
Allowance for doubtful accounts at the end of the period	$	912,205		$	608,356

Inventory, Policy [Policy Text Block]

Inventory-- Inventory is carried at the lower of cost or market, as determined on the first-in, first-out method.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment-- Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets which range from three to ten years (See Note 3).

Investment, Policy [Policy Text Block]

Long-Term Investments-- Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information may be more limited, may not be as timely as and may be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.

Goodwill and Intangible Assets, Policy [Policy Text Block]

Intangible Assets-- Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC”) Topic 350, “Goodwill and Other Intangible Assets” and amortized the patents on a straight line basis over the estimated useful life of two to ten years.

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Goodwill - Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition and Sales Incentives-- The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (SAB 101), FASB ASC 605 Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collection of the resulting receivable is reasonable assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.

The Company has received various long-term contracts for the manufacturing and installation of water filtration and treatment systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long term or grant multiplied by the contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.

Project costs of the long term contracts and grants include all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.

In Denmark, Value Added Tax (“VAT”) of 25% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.

Advertising Costs, Policy [Policy Text Block]

Advertising Cost-- Cost incurred in connection with advertising of the Company’s products is expensed as incurred. Such costs amounted to $17,120 and $30,556, for the nine months ended September 30, 2014 and 2013, respectively.

Research, Development, and Computer Software, Policy [Policy Text Block]

Research and Development Cost-- The Company expenses research and development costs for the development of new products and systems as incurred. Included in operating expense for the nine months ended September 30, 2014 and 2013 were $223,532, and $350,515, respectively, of research and development costs.

Income Tax, Policy [Policy Text Block]

Income Taxes-- The Company accounts for income taxes in accordance with FASB ASC Topic 740 Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.

Earnings Per Share, Policy [Policy Text Block]

Income (Loss) Per Share-- The Company calculates earnings (loss) per share in accordance with FASB ASC 260 Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options that have been granted but have not been exercised.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock Options-- The Company has granted stock options to certain employees. See Note 13. During the years presented in the accompanying consolidated financial statements, the Company has granted options. The Company accounts for options in accordance with the provisions of FASB ASC Topic 718, Compensation – Stock Compensation. Non-cash compensation costs of $372,960 and $1,051,857 have been recognized for the estimated vesting of options granted to employees with an associated recognized tax benefit of $0 for the nine months ended September 30, 2014 and 2013, respectively.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value of Financial Instruments-- The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic 820. The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

● Level 1. Observable inputs such as quoted prices in active markets for identical assets or liabilities;

● Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

● Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.

Use of Estimates, Policy [Policy Text Block]

Accounting Estimates-- The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements-- In May 2014, the Financial Accounting Standards Board issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard is effective beginning in the first quarter of 2017; early adoption is prohibited. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method nor have we determined the impact of the new standard on our consolidated condensed financial statements.

XML

Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2014

Disclosure Text Block [Abstract]

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Year ending December 31,	Amortization Expenses
2014	$	1,325
2015		5,299
2016		5,299
2017		3,218
2018		2,707
Thereafter		782
Total Amortization Expenses	$	18,630

Schedule of Goodwill [Table Text Block]

	For the periods ended
	September 30, 2014			December 31, 2013
Goodwill at beginning of period	$	-		$	-
Goodwill resulting from the Provital acquisition		8,547,540			-
Effect of currency translation		(567,213	)		-
Goodwill at end of period	$	7,980,327		$	-

Schedule of Intangible Assets and Goodwill [Table Text Block]

	For the periods ended
	September 30, 2014		December 31, 2013
Provital Solutions AS	$	7,980,327	$	-
Total Goodwill	$	7,980,327	$	-

XML

Note 9 - Income Taxes (Details) (Earliest Tax Year [Member])	9 Months Ended
	Sep. 30, 2014
Foreign Tax Authority [Member] | Danish Ministry of Taxation [Member]
Note 9 - Income Taxes (Details) [Line Items]
Open Tax Year	2011
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Note 9 - Income Taxes (Details) [Line Items]
Open Tax Year	2009
State and Local Jurisdiction [Member]
Note 9 - Income Taxes (Details) [Line Items]
Open Tax Year	2009

XML

Note 5 - Definite-Life Intangible Assets / Goodwill and Indefinate-Life Intangible Assets (Details) - Expected Future Amortization Expense (USD $)	Sep. 30, 2014
Expected Future Amortization Expense [Abstract]
2014	$ 1,325
2015	5,299
2016	5,299
2017	3,218
2018	2,707
Thereafter	782
Total Amortization Expenses	$ 18,630

XML

(Unaudited) Consolidated Statements of Other Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net Income (Loss)	$ 344,589	$ (903,994)	$ (1,176,097)	$ (2,896,066)
Currency Translation, Net of Taxes	(1,852,400)	93,635	(1,874,600)	70,836
Other Comprehensive Income (Loss)	(1,507,811)	(810,359)	(3,050,697)	(2,825,230)
Comprehensive Income (Loss) Attributable To Non-controlling Interest in Subsidiaries	(1,745)	920	(1,928)	704
Comprehensive Income (Loss) Attributable To LiqTech International Inc.	$ (1,506,066)	$ (811,279)	$ (3,048,769)	$ (2,825,934)

XML

Note 4 - Investments

9 Months Ended

Sep. 30, 2014

Investments, Debt and Equity Securities [Abstract]

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

NOTE 4 – INVESTMENTS

The following tables summarize Level 1, 2 and 3 financial assets and financial (liabilities) by their classification in the Statement of Financial Position:

As of September 30, 2014	Level 1		Level 2		Level 3
Investments		-		-		6,297
Total		-		-		6,297

As of December 31, 2013	Level 1		Level 2		Level 3
Investments		-		-		6,882
Total		-		-		6,882

At September 30, 2014 and December 31, 2013, our total investments of $6,297 and $6,882 consisted of an investment in LEA Technology in France to strengthen our sales channels in the French market, respectively.

XML

Note 11 - Stockholders' Equity (Details) - Options Outstanding (USD $)	9 Months Ended
	Sep. 30, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Number outstanding (in Shares)	2,416,630
Options Weighted average remaing contractual life	292 days
Options Weighted average exercise price	$ 2.59
Options Number exercisable (in Shares)	2,083,297
Options Weighted average exercise price, exercisable	$ 2.70
Price Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, upper	$ 1.50
Options Number outstanding (in Shares)	330,000
Options Weighted average remaing contractual life	146 days
Options Weighted average exercise price	$ 1.50
Options Number exercisable (in Shares)	330,000
Options Weighted average exercise price, exercisable	$ 1.50
Price Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, upper	$ 1.90
Options Number outstanding (in Shares)	500,000
Options Weighted average remaing contractual life	2 years 120 days
Options Weighted average exercise price	$ 1.90
Options Number exercisable (in Shares)	166,667
Options Weighted average exercise price, exercisable	$ 1.90
Capital Lease 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, upper	$ 2.70
Options Number outstanding (in Shares)	75,000
Options Weighted average remaing contractual life	146 days
Options Weighted average exercise price	$ 2.70
Options Number exercisable (in Shares)	75,000
Options Weighted average exercise price, exercisable	$ 2.70
Capital Lease 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower	$ 3.00
Range of exercise price, upper	$ 3.60
Options Number outstanding (in Shares)	1,511,630
Options Weighted average remaing contractual life	149 days
Options Weighted average exercise price	$ 3.06
Options Number exercisable (in Shares)	1,511,630
Options Weighted average exercise price, exercisable	$ 3.06

XML

Note 7 - Leases (Tables)

9 Months Ended

Sep. 30, 2014

Leases [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

Year ending December	Operating Lease Payments
2014	$	169,334
2015		695,240
2016		693,791
2017		482,503
2018		287,962
Thereafter		-
Total Minimum Lease Payments	$	2,328,830

Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]

	Capital Lease Payments
2014	$	70,077
2015		223,548
2016		216,916
2017		145,029
2018		28,282
Thereafter		-
Total minimum lease payments		683,852
Less amount representing interest		(65,669	)
Present value of minimum lease payments		618,183
Less current portion		(181,595	)
Long-term lease payments	$	436,588

XML

Note 4 - Investments (Details) (LEA Technology [Member], USD $)	Sep. 30, 2014	Dec. 31, 2013
LEA Technology [Member]
Note 4 - Investments (Details) [Line Items]
Investments	$ 6,297	$ 6,882

XML

Note 14 - Subsequent Events

9 Months Ended

Sep. 30, 2014

Subsequent Events [Abstract]

Subsequent Events [Text Block]

NOTE 14 – SUBSEQUENT EVENTS

The Company’s management reviewed material events through November 12, 2014.